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Translational Biomedical Informatics (TBMI) is an emerging discipline 
expanding beyond traditional bioinformatics, with a focus on developing computational 
technologies for real-world biomedical practice. The goal of my Ph.D. research is to 
address a few key challenges in TBMI, including: (1) the high quality and reproducibility 
required by medical applications when processing high throughput data, (2) the need for 
knowledge management solutions that allow molecular data to be handled and evaluated 
by researchers, regulators, and doctors collectively, (3) the need for near real-time, 
efficient access to decision-oriented visualizations of integrated data and data processing 
results, and (4) the need for an integrated solution that can evolve as medical consensus 
evolves, without requiring retraining, overhaul or replacement. The problem statement of 
this dissertation is that new molecular data is too bulky, clumsy, error-prone, 
heterogeneous, and difficult to interpret to be useful in a real-word clinic with existing 
informatics technologies. This dissertation addresses this problem with three overall 
objectives:  
Information Management: To develop novel data handling systems that improve 
quality, search-ability, and efficient archival and maintenance of high throughput data.  
Visualization: To develop a web-based visualization system that enables fast and 
effective biomedical decision-making using standard formats to represent heterogeneous 
molecular data.  
Translation: To enable standardization and clinical workflow integration of 
biomedical informatics by contributing to quality standards consortia for molecular data 
 xiii
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and deploying semantically annotated solutions to the wider cancer community through 
cancer Biomedical Informatics Grid (caBIG). 
The accomplishment of these aims was guided by 3 design principles. Each of 
these principles is an important component of robust medical software. The first principle 
is use of open-source software platforms instead of proprietary formats, because this 
allows for the investigation of technical problems at the deepest possible level. The 
second principle is the use of web-based “software-as-a-service” architecture for 
maximum portability and accessibility of the solution. The third principle is the use of 
open standards for data formats whenever they exist to aid in interoperability. The choice 
of technologies such as PHP, MySQL, SVG, and PNG were all guided by these 
principles. These principles are aligned with those of the caBIG community. 
This dissertation resulted in the development and adoption of concrete web-based 
application deliverables in regular use by bioinformaticians, clinicians, biologists and 
nanotechnologists. These include: the Chip Artifact Correction (caCORRECT) web site 
and grid services, the ArrayWiki community microarray repository, and the 
SimpleVisGrid visualization grid services (including eGOMiner, nanoDRIVE, 







This introduction will present the four grand challenges to Translational 
Biomedical Informatics: stability and security, information integration, multi-scale 
analysis and queries, and translation to clinical workflows. No lone researcher can make 
a significant impact on these grand challenges, but I present how these problems shaped 
the development of the Specific Aims of this dissertation. 
Motivation for Translation Biomedical Informatics 
Bioinformatics has traditionally been concerned with computational molecular 
biology (e.g. sequence alignment, structure prediction, and molecular dynamics 
modeling). Translational Biomedical Informatics (TBMI) is an emerging field that 
focuses on developing computational technologies for real-world biomedical practice. 
These technologies do not replace the medical professional, but rather empower him/her 
to achieve higher diagnostic accuracy and to more efficiently treat disease. The goal of 
this research is to address three key challenges for TBMI enabling bioinformatics to be 
translated into medicine and positively impact human health. These challenges are 
directly related to society-wide problems of the cost of health care and the prevention of 
medical errors that can carry a high societal cost. 
The key challenges that differentiate bioinformatics and TBMI are: (1) the high 
quality and reproducibility required by medical applications when processing high 
throughput data, (2) the need for knowledge management solutions that allow molecular 
data to be handled and evaluated by researchers, regulators, and doctors collectively, (3) 
the need for near real-time, efficient access to decision-oriented visualizations of 
integrated data and data processing results, and (4) the need for an integrated solution that 
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can evolve as medical consensus evolves, without requiring retraining, overhaul or 
replacement.  
Some of these challenges have been raised in the field of medical informatics. 
However, medical informatics remains grounded in the concept of the patient record. 
This has prevented standardization as systems ultimately submit to the immediate needs 
of treating patients. Over time, meta-data becomes as free-form, individually-tailored, 
and difficult to mine as the patient whose medical record it represents. TBMI must 
address these challenges while also building a bridge between these operational and the 
scientific approaches, opening the floodgates for the vast quantity of data soon to be 
available without causing the health care system to drown in it. 
Figure 1 illustrates the problems with integrating new types of high-throughput 
molecular data into the patient record by giving examples of the diversity of data that is 
becoming available and the complexity of the relationships between these virtual 




Figure 1: Data management challenges of personalized medicine. As molecular detection 
technology advances, traditional medical informatics approaches designed to handle only 
traditional clinical data will become a bottleneck for clinical translation and ultimately for 
diagnosis in the clinic. Four new types of data are growing rapidly. Genotyping 
information helps the doctor predict how a patient’s systems will react to disease and to 
treatment based on hard-coded predispositions in his/her genome. Molecular Imaging 
data gives location and morphology information to further understand the scale of a 
disease, plan treatment, and evaluate success. Molecular abundance data forms a large-
scale biochemical profile which can be compared to a database of previous patients and 
outcomes to make predictions about disease aggression or treatment response. Finally, all 
of these predictions must be updated, aggregated and compared to other patients to 
supply more knowledge for the benefit of future patients. 
 
 3
The Three Grand Challenges of Biomedical Informatics 
Information technology has been much slower to impact the medical community 
than other communities in research and in industry. There are very good reasons for this 
delay. First, there are the problems of the expense of acquiring data and the resulting data 
scarcity because the health care research environment is heavily regulated in the interests 
of societal ethics. Second, there are the further ethical issues around personal data privacy 
and de-identification once it has been acquired. Finally, there are issues of countless 
complicating external factors in medicine and health that make quantitative analysis and 
interpretation of results extremely challenging. All of these contribute to the problem 
statement of this dissertation: that new molecular data is too bulky, clumsy, error-prone, 
immature in acquisition methods, heterogeneous, and difficult to interpret to be useful in 
a real-word clinic with existing informatics technologies. 
Stability and Security 
The innate ethical sensitivity of medical data means the need for security is of 
primary importance. The time-sensitive nature of delivering medical care means that 
stability is also critical. Both of these challenges are related in that an unstable system is 
more vulnerable to security attacks. Many high-profile data leaks in recent years have 
demonstrated that human factors (e.g. not following data security policies or installing 
systems that have not been reviewed) are a major source of security holes. However, in 
the defense of human intelligence, data security policies are too complicated and most 
software systems do not use simple techniques such as gentle reminders or automated 
security audits to help users prevent intruders. 
Two important aspects of the stability and security problem that guided design 
principles of this dissertation are the use of data formats that may contain corrupt, invalid 
data (or even malware developed by cyber attackers) and the use of proprietary systems 
that may not receive regular security updates if the development team is not committed to 
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the ongoing support of the system. Data that can be validated by human and by 
automated computer programs is an important advancement for improving stability and 
security of medical software. Another important advance is the advent of community-
based and non-profit computing platforms like The Wikipedia Foundation and the NCI 
Cancer Biomedical Informatics Grid (caBIG), which do have a public charter to create 
long-lasting and secure resources for the common good. 
Information Integration 
TBMI is an interdisciplinary field with very few participants that have the good 
luck to be trained and practiced in all aspects. For this reason, in any meeting of 
biologists, biomedical engineers, computational scientists, and clinicians, some audience 
members can be confused by discussions that go to a substantial amount of technical 
depth (whether they admit it or not). This is due to the importance of language training in 
integrating new information into the human brain. The more comfortable someone seems 
in using a word that has no meaning for the listener, the more uncomfortable the listener 
gets and the harder it becomes to effectively communicate. 
Turning to computational technologies can help overcome these barriers. 
Resources like Wikipedia (http://www.wikipedia.org) allow for deep investigation into 
new subjects at a much faster rate than when reference books had to be located, browsed 
and digested. However, for computational algorithms to accomplish the same feat, they 
require more than simple text found in web articles and scientific literature to 
differentiate between similar concepts. Ontologies are an important tool for allowing 
computer software to make these distinctions with the same ease as the human brain. 
Semantic annotation of data is the process of mapping all data using identifiers from a 
common ontology so that computers can reference the meaning of data by performing a 
database look-up. 
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The best example of a medical research community tackling the problem of 
information integration is the National Cancer Institute’s (NCI) Cancer Biomedical 
Informatics Grid (caBIG) [1]. This national initiative has been held up by the Director of 
the National Institutes of Health (NIH) as an example for other medical fields to follow. 
Already, new projects such as the Cardiovascular Research Grid 
(http://www.cvrgrid.org/) from the National Heart, Lung, and Blood Institute are being 
proposed and are entering their pilot phases based on the framework and success of 
caBIG. 
Advances in eCommerce and eScience have shown that better information 
technology infrastructure can stimulate long-term scalability, community involvement 
and synergy. However, biomedical infrastructure projects face unique challenges such as 
(1) the rigorous scientific validation demanded by the ethics of medical practice, (2) the 
urgency arising from deploying systems into an environment designed for daily 
confrontations with human illness, and (3) the organizational problems that naturally 
arise in multidisciplinary collaborative research. Addressing these challenges requires 
more than just the technology approach, but the solutions presented in this dissertation 
will be limited to how information technology enhances the process of translating to the 
clinic [2, 3].  
Multi-Scale Analysis, Queries, and Data Summaries 
Biomedical informatics visualization research can be traced back to the 1970s, 
when Game of Life [4], a two-dimensional cellular automaton invented by John H. 
Conway was published in Scientific American. For many years, until the completion of 
the Human Genome Project in 2001 [5-7], bioinformatics tools were primarily (1) 
simulations with limited underlying experimental data (high-throughput methods such as 
microarrays and mass spectrometry were not commonly used); and (2) comparative tools 
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with limited test cases (the fundamental similarity of the genetic code for all of life had 
not been confirmed) [8].  
In the post-genome era, advanced high-throughput biotechnologies generated 
large amounts of experimental data, and the birth of Internet during the past decade has 
made much of these data accessible for effective worldwide collaboration. This has 
spurred the bioinformatics community to search for innovative techniques to manage and 
explore these data to drive new discoveries [9, 10]. Many predict that this flood of data is 
just beginning, which makes translational bioinformatics an exciting field for modern 
biomedical research [11]. For example, with much more data there is a possibility to 
model the flow of information in living systems for us to get a deeper understanding of 
how these systems are sustained and what mechanisms cause them to break down.  
Biomedical researchers today are overwhelmed by the quantity of data, and are 
underwhelmed by the limited usability offered by many tools. This has caused the 
generation of knowledge, which requires human intervention, to lag behind the 
generation of data. Quality integrated systems will speed up new discoveries in biology 
and medicine by allowing researchers to increase the scale and scope of their 
investigations. Knowledge can be generated by large-scale integrated systems at a rate 
similar to experimental data as technologies for biological data handling and comparison 
become more sophisticated. With each successive large-scale project publication, 
interactive utilities for exploration and visualization of data become more important. 
Examples of innovative interactive visualization and exploration tools include Databse 
for Annotation, Visualization, and Integrated Discovery (DAVID) [12], GeneWindow 
[13] and the Genome-Phenome Superhighway (GPS) [14, 15]. In addition to accessing a 
vast data resource of value for primary research, good visualization technologies are also 
portable and simple to access. For visualization in the clinical setting, standard 
applications should be used to launch visualizations without requiring support from the 
local information technology experts. 
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The Organization of This Thesis 
This dissertation addresses the challenges mentioned above by applying 
engineering design toward three fundamental software metrics: interoperability, usability, 
and adaptability. The three overall objectives of this research were: (1) Information 
Management: To develop novel data handling systems that improve quality, search-
ability, and efficient archival and maintenance of high throughput data, (2) Visualization: 
To develop a web-based visualization system that enables fast and effective biomedical 
decision-making using standard formats to represent heterogeneous molecular data, and 
(3) Translation: To enable standardization and clinical workflow integration of 
biomedical informatics by contributing to quality standards consortia for molecular data 
and deploying semantically annotated solutions to the wider cancer community through 
cancer Biomedical Informatics Grid (caBIG). 
These objectives lay out a technical framework for facilitating necessary steps in 
clinical translation. Chapters 2 and 3 of this dissertation address two components of the 
Information Management solution: quality control and data discovery. Chapter 4 
addresses the Visualization solution. Chapters 5 and 6 address two components of the 
Translation solution: the Food and Drug Administration’s (FDA) Microarray Quality 
Control (MAQC) Phase II effort and integration of the concrete deliverables into caBIG.  
Each chapter covers background and significance, gives a technical explanation of the 
system design, and presents results and documentation of the concrete deliverable. Figure 
2 shows how the tools discussed here map to the engineering design factors and the 
chapter organization. Many tools represent a combination of two factors, but are 
presented in the chapter that is most relevant. It is expected that this research platform 
will be used to support ongoing translational research, both at Georgia Tech and Emory 
and in the wider community. 
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Information Management 
The first objective of this dissertation was to develop novel data handling systems 
that improve quality, search-ability, and efficient archival and maintenance of high 
throughput data. This aim can be measured by how well a technology improves 
interoperability of data. The key metrics of interoperability for TBMI are data quality, 
portability of data formats, and public sharing of data. 
Quality Control 
Information management enables information to be passed between many 
participants in an information workflow. An example of this is web lab experimenters 
passing data acquisition results to computational experts for analysis. The trust between 
collaborators in this field is founded on good data quality control. My key contribution in 
this aim is the development of a web-based system for evaluating the quality of high-
throughput microarrays. The quality is evaluated in two ways: visual heatmaps of the data 
variance that can help laboratory experimenters diagnose problems in their protocols and 
an algorithmic quality score that can estimate the relative quality of high-throughput 
experiments by scoring each individual chip. Some have suggested that understanding the 
timeline that an experiment was performed on is one of the most important indicators of 
quality [16]. We agree with this assessment and have emphasized tracking of data 
acquisition time to highest possible level of detail. 
Information Integration and Data Discovery 
The second component of the first objective of this dissertation was the 
development of a community-maintained platform for microarray data using a novel data 
compression and visualization format. ArrayWiki supports information integration and 
data discovery because of the union of a generalized information representation syntax 
that is both human- and machine-readable, pioneered by the Wikipedia Foundation. This 
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platform, ArrayWiki, is at the center of the axes in Figure 2 because it incorporates all of 
the aims of this dissertation.  
ArrayWiki facilitates translation because of the Wiki framework, which involves 
all community members in discussions of data quality and annotation of the multitudes of 
microarray experiments, including many clinical experiments. This community 
involvement is a method to ensure that data remains fresh and up-to-date. ArrayWiki also 
represents an advance in visualization because it uses the BioPNG  format for data 
compression and storage (discussed in Chapter 4). ArrayWiki supports the effort for 
better quality control because over 20,000 microarray chips have been imported and 
automatically processed by the caCORRECT algorithms. The cleaned chip data is 
available for download by any user on the Internet. Finally, ArrayWiki is most relevant 
for information management, because the Wiki framework can be extended to support 
many other types of molecular data, such as mass spectrometry, molecular imaging, or 
Surface Enhanced Raman Spectroscopy (SERS) nanoparticle data. 
Web-based Visualization for Effective Interpretation and Integration of Data 
Biomedical Informatics has experienced an explosion in data analysis tools in 
response to the dramatic growth of molecular data. The biomedical researcher from a 
non-computational background is similarly bewildered by this array of tools as they are 
by the task of data management. The second objective of this dissertation is to develop a 
web-based visualization system that enables fast and effective biomedical decision-
making using standard formats to represent heterogeneous molecular data.  
This aim addresses challenges of enabling efficient access to information in a fast-
paced environment. This aim can be measured by how well the technology improves 
usability of tools. The key metrics of usability for TBMI are accessibility through the 
web, flexibility in visual rendering, and responsiveness even when handling high-
throughput data.  
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The visualization system described here is designed to be available on a national 
computational grid called caGrid, which was built by the caBIG initiative. The system 
supports visualization of biochemical networks, semantic (or ontological) relationships 
such as Gene Ontology, correlations and correspondences between analysis results such 
as mining for biomarkers in molecular data, and high-throughput data acquisition results 
such as molecular imaging and microarray scanners. The key contribution of this research 
is that it expands existing technology standards to allow for embedding of the complete 
source data for a visual representation into the same file that provides the visual data. 
Translation 
At an information crossroads between many interdisciplinary fields (e.g. 
molecular biology, chemistry, engineering, and medicine), TBMI researchers face a 
challenge to develop solutions that facilitate increasingly complex research workflows 
(see Figure 3). The third objective of this dissertation is to enable standardization and 
clinical workflow integration of biomedical informatics by contributing to quality 
standards consortia for molecular data and deploying semantically annotated solutions to 
the wider cancer community through cancer Biomedical Informatics Grid (caBIG).  
This aim can be measured by how easily the wider informatics community can 
incorporate new analytical processes into existing data workflows. This ability is related 
to a software engineering design factor called adaptability.  
FDA MAQC Phase II Consortium Case Study 
The second phase of the Food and Drug Administration (FDA) Microarray 
Quality Control (MAQC) project studied common methods for building models (i.e. 
biomarker mining and classification algorithms) from microarray data to predict disease 
outcomes or drug response. Thirteen clinical scenarios (called “endpoints”) were 
designed using six datasets (a total of 2276 microarray samples). Thirty-six teams trained 
classifiers using this data and a wide diversity of data analysis protocols (DAPs) over a 
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period of one year. Validation data was released to these teams after each one had 
publicly selected their “best model” from all of their research. These models were finally 
compared using this blind validation and another performance result was obtained by 
training on the new validation data a second time and testing on the original data. DAPs 
were evaluated in terms of simplicity, reproducibility (i.e. low performance variance on 
new data), and reliability (i.e. predictable performance on new data). One classifier found 
to perform well was K Nearest Neighbors (KNN). The goal of my contribution to this 
study was to determine to what extent KNN parameters explained the performance 
difference between KNN DAPs and to what extent extrinsic properties like data quality 
played a role. This large-scale example of Team Science is important because the FDA is 
responsible for approving new technologies like microarrays for use in real-world clinical 
practice. 
caBIG Silver-Level Certification 
The cancer Biomedical Informatics Grid (caBIG) is a large-scale initiative of the 
National Cancer Institute (NCI) to develop a common software platform for all of cancer 
research. This effort is currently moving from the Pilot Phase (where the emphasis has 
been on building tools and proving the infrastructure) to the Enterprise Phase (where the 
emphasis is on adoption and training the clinical research community). In the Enterprise 
Phase, universities and private companies have been encouraged to deploy their tools to 
the grid to add value to the overall program. A certification system was set up with 
Bronze, Silver, and Gold-level certification requirements to guide contributing software 
developers toward high quality interoperable systems. The Gold-level certification is only 
available to tools that have already passed Silver-level, and the best practices aren’t ready 
for mainstream developers. My contribution to this effort was to build a package for 
Silver-level certification of caCORRECT Grid Services and to design SimpleVisGrid to 
be ready for the same process. The certification review process can be thought of as a 
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peer review process to decide if systems already accepted as science by the community 
(as evidenced by publication) can be called Team Science. 
 
 
Figure 2: Overview of tools developed (or adopted in the case of caNanoLab and caGrid) 
for this dissertation. The tools presented here are organized by the most relevant objective 
or design factor. Chapter 2 will discuss caCORRECT and quality control. Chapter 3 will 
discuss ArrayWiki and information management. Chapter 4 will discuss BioPNG and 
SimpleVisGrid. Chapter 5 will discuss the FDA MAQC project (application of quality 
control to the regulatory community to facilitate translation). Chapter 6 will discuss 





Figure 3: The Biomedical Research Workflow. As interdisciplinary research, 
Translational Bioinformatics must focus on technologies that are useful and 
understandable to scientists from many backgrounds. Tools developed specifically for 
one step in this workflow must interoperate with tools at other steps to avoid friction (i.e. 
time wasting) and quality problems associated with data transfers and data formatting. 
For example caCORRECT is specifically designed for “Data Quality Assurance”, but it 
must interoperate with “Knowledge Mining” tools like those studied under the FDA 
MAQC, and with “Clinical Validation and Interpretation” tools like ArrayWiki because 
problems validating a biomedical solution may trace back to problems in the “High-
Throughput Data Acquisition” step. 
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The System Design Factors 
Three computational design factors will be discussed in this dissertation, because 
they influence both the choice of technologies and the priorities used in daily tasks of 
developing robust software. These design factors are usability, adaptability, and 
interoperability. I have identified the typical approaches to addressing the three 
computational design factors, and I highlight the importance of standardization for 
improving all three. In addition, the concrete deliverables of this dissertation represent 
technical solutions to the stated problems. For interoperability and adaptability, data 
quality standards and interfaces to a large-scale community project is demonstrated by 
caCORRECT. For adaptability, ArrayWiki is an example of an even more flexible 
community-based resource for enabling the community to monitor the currency of data. 
For usability and interoperability, the grid-based visualization technologies BioPNG and 
SimpleVisGrid combine open-standard formats and semantically-annotated service 
descriptions for use by caCORRECT, ArrayWiki, and many other domain-specific 
applications described in Chapter 4. Figure 4 illustrates the complex relationship between 
users, systems, and the design factors that make systems more useful for medical 
research. These developments are of importance not only to bioinformaticians, but also to 
clinicians and to government agencies such as the National Institutes of Health and 







Figure 4: Translational Bioinformatics System Design Factors. A. Using software to stop 
disease. All biomedical researchers are interested in usability and verifiability of the 
system. The end user should be protected in some ways from the complexity “under the 
hood.” B. Most bioinformatics research prototype systems are not friendly enough for use 
by people without computational knowledge. Computer Scientists have the knowledge of 
algorithms to extract useful knowledge from data, but they don’t have the technical 
background to acquire high quality data or fully understand the data acquisition process. 
Bioengineers must understand the data and how to draw relationships between data to 
connect these two groups and create useful systems. 
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 CHAPTER 2 
 
CHIP ARTIFACT CORRECTION (CACORRECT) QUALITY 
CONTROL FOR ARRAY DATA 
The first objective of this dissertation was to develop novel data handling systems 
that improve quality, search-ability, and efficient archival and maintenance of high 
throughput data. This aim can be measured by how well a technology improves 
interoperability of data. The key metrics of interoperability for TBMI are data quality, 
portability of data formats, and public sharing of data. This design factor is introduced 
first in this chapter, and then the background for microarray quality control is presented. 
Finally, results of caCORRECT are presented, based on its original publication in Annals 
of Biomedical Engineering [18]. Finally, new directions are discussed. 
Interoperability 
Interoperability is defined as the ability for independently-developed software 
systems to share information. Interoperability is important because it enables software 
systems to expand functionality with minimal duplication of development effort. 
Interoperable modules may be plugged into research workflows to easily test new 
approaches to data analysis. Interoperability adds a new layer of complexity to integrated 
systems and requires stable data standards and infrastructure.  
For some time in the early days of bioinformatics, true interoperability was 
avoided by the development of huge data warehousing efforts [19]. Enormous centralized 
databases were proposed supposedly to contain all of biological knowledge. These efforts 
were usually soon abandoned due to costs in keeping data current [20, 21]. The 
underlying reasons for these failures are the distributed nature of biological knowledge 
into specializations and the dynamic and unpredictable nature of ongoing research and 
discovery. 
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Currently, most computational researchers agree that distributed solutions are the 
most likely to last in such a dynamic field. No organization can possibly implement 
innovative solutions to every biological problem. Web services have become the vision 
of the future of e-Science, including bioinformatics [9, 22]. The importance of web 
services is that those organizations with specialized information to share with the 
community have freedom to change the underlying data models behind their services 
without creating instability for other systems that use their data. The only requirement is 
that their services continue to support the pre-defined transaction types (a.k.a. application 
programming interfaces (APIs)). This decoupled model between data consumers and 
developers also improves adaptability. Still, there are many research teams that follow a 
stand-alone software distribution model where developers must compile and release 
platform-dependent application versions and support them until they can persuade their 
users to upgrade locally installed software. 
The web services model is ideal for creating integrated solutions because no 
single organization is required to maintain all of the specialized working parts. Web-
based services tend to lead to more stable and robust software because replacing a service 
can be as simple as changing a single URL, allowing software to evolve by replacing 
obsolete components quickly as new solutions are developed. One missing component of 
this model is a set of standards for communicating about the quality of the services that 
are offered, and thus human intervention is still necessary for systems to evolve. 
Adoption of community standards is a recurring theme throughout this 
dissertation. Figure 5 is designed to show relationships between communication 
standards developed for computer scientists, those that have been applied to 
bioinformatics, and the corresponding move from specificity to generality in the data 
contained in these standards. 
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Interoperability Standards 
The lowest three levels in Figure 5 deal with interoperability standards. In the 
early days of Internet computing, transport interoperability was the primary data handling 
technique, including transferring tapes and floppy disks between laboratories. Computer 
networking and the World Wide Web greatly eased the physical burden of this layer. 
Some of the greatest recent advances in interoperability are the Transmission Control 
Protocol (TCP-IP) (1974), Hypertext Transfer Protocol (HTTP) (1990), and Extensible 
Markup Language (XML) (1996). At the Data Types layer, many developers often wrote 
custom data formatting code for each platform. XML standards have greatly reduced the 
need for custom code.  
Interoperability in TBMI is more complicated. Teams of collaborators are often 
composed of experimental scientists who specialize in collecting data and 
bioinformaticians who specialize in analyzing data. These teams require increasingly 
advanced methods to ensure that data was collected and transferred with the correct 
associated meta-data. Data handling and quality control involves proper identification of 
outliers that were caused by noisy data measurement techniques. The system must 
employ reliable identification techniques to ensure that it is comparing “apples to apples” 
as opposed to throwing out important variations that might lead to an important 
discovery. For this reason, the development and adoption of data identification standards 
is also critical to the success of this approach. 
Data Identification Standards 
The vast array of identification schemes for genes, proteins, metabolytes and 
other biological species adds complexity to the interoperability of data handling systems. 
Web services such as GeneCruiser [23] have been developed to assist in translation 
between differing identification schemes. The FDA Microarray analysis workbench, 
ArrayTrack [24], also contains ID translation functionality, built on top of the 
Bioconductor [25] package for the R programming environment. Data identification 
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standards may be the route to improving the ability to merge experiments that contain 
heterogeneous data acquisition platforms. A good introductory effort to integration of 
heterogeneous data is the Biozon database [26], which is an attempt to collect data from 
the most often-cited databases and provide a unified search tool that can categorize and 
rank results based on the Google PageRank [27] model. The categories available in 
Biozon are Protein Families, Pathways, Proteins, Domains, Structures, Interactions, 
Nucleic Acids and Unigene Cluster. The Life Sciences Identifier (LSID) [28] shows the 
most promise for uniting these identification schemes, but due to the immature status of 
this standard, it does not play a definite role in interoperability today.  
Ontologies: Vocabulary Standards 
Vocabulary standards are collectively known as ontologies. The goal of biological 
ontologies is to precisely define the vocabulary used in research, so as to reduce 
confusion between researchers that use the same words or glyphs (graphical indicators) to 
identify or describe very different entities. A common example is the word ‘agent’, which 
can indicate a biologically active molecule, an autonomous computer program, a 
government worker, or a financial representative, etc. depending on the context.  
Bioinformatics tools have necessitated the development of ontologies because 
they are increasingly expected to interpret the language of researchers. This requires the 
ability to cross-reference terms and place them appropriately in an increasingly complex 
biological context. The impact of these ontologies, created initially by bioinformaticians, 
will be felt throughout the medical and biological research communities as the definitions 
of common words are necessarily narrowed, broadened, or reassigned for clarity in the 
computational setting. 
Ontologies are 1) dictionaries of terms with definitions, usually organized in a 
conceptual hierarchy, rather than alphabetically; 2) a formal way of organizing 
discussions around what people mean when they use certain terms; and 3) a conceptual 
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map of a domain, which may be used for visualization or calculations of distances 
between ideas. 
Ontologies as a systematic specification of language for a large community are 
not an entirely new concept. Mathematics and electronic circuit theory are two familiar 
examples of ontologies that include terminology and glyphs. While some might describe 
the development of these ontologies as a laborious process, it is hard to dispute their 
success in allowing scientists from different disciplines to communicate specific 
problems and solutions with minimal confusion.  
Biomedical ontologies are expected to have a future impact comparable to the 
impact of mathematics and electronic circuit theory. They will demystify the biological 
area of knowledge by breaking down concepts into their component parts, allowing 
researchers to move between different levels of detail in their discussions while 
(hopefully) avoiding semantic conflicts that inhibit the discovery process. 
Biomedical Data Quality and Data Sharing Standards 
Many interdisciplinary groups have published papers about the lack of 
reproducibility of biological experimental results due to lack of information provided 
about data acquisition protocols and data analysis protocols [29-31]. Initiatives such as 
Minimum Information About a Microarray Experiment (MIAME) [32] and Minimum 
Information Requested in the Annotation of Biochemical Models (MIRIAM) [33] have 
attempted to set guidelines for meta-data sharing to improve reuse of existing 
experimental data for new purposes. Finally, quality surveys (including Phase I one of 
FDA MAQC) have shown that microarrays are susceptible to many sources of noise, and 
that noise reduces the reproducibility of downstream results [16, 34-37]. These standards 
efforts in the microarray field have been mirrored in related high-throughput fields such 




Figure 5: The Translation Biomedical Informatics Software Standardization Stack. This 
chart presents the progression of developments toward standardization of software system 
design. It is inspired by and an extension of the Network Communications Protocol Stack 
(see http://en.wikipedia.org/wiki/Protocol_stack for details). Progressing upwards 
through the chart, it is important to note that standardization becomes more difficult as 
requirements move from the Objective (or concrete) type to the Subjective (or personal 
preference) type. The question mark at the top indicates that usability standards are 
difficult to identify and represent important future work. The parallel upward progression 
of knowledge integration in the life sciences field is meant to help non-computational 
readers to understand the change from concrete requirements, such as syntax or timing 
requirements for very specific devices, to general requirements such as how to represent 
over-arching concepts in information embodiments. Just as life sciences have become 
rooted in the foundation of understanding molecular (and even quantum) interactions, 
software design is rooted in the foundation of information transport. However, as 
concrete data gives way to abstract ideas, it becomes difficult to reach consensus, and 
therefore the standards must become more flexible. 
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Chip Artifact Correction (caCORRECT) for High-Throughput Quality Control 
I developed a web-based tool to support the first objective of this disertation. 
caCORRECT is a web-based quality assurance process for Affymetrix microarrays. 
Affymetrix is the most popular and most widely available microarray technology and our 
system supports any of their 50+ chip platforms. caCORRECT has garnered an 
international user base and has been deployed to the Cancer Biomedical Informatics Grid 
(caBIG) in the form of semantically annotated grid services. The caCORRECT system 
has been run on over 20,000 microarray samples as part of loading the ArrayWiki 
community web site. Finally, we have used caCORRECT to support the Food and Drug 
Administration (FDA) Microarray Quality Control (MAQC) Phase II effort to validate 
the reproducibility of predictive models based on microarray data.  
Quality assurance of high throughput “–omics” data is a major concern for 
biomedical discovery and translational medicine, and is considered a top priority in 
translational biomedical informatics (TBMI). caCORRECT is a web-based 
bioinformatics tool for chip artifact detection, analysis, and correction, which removes 
systematic artifactual noises that are commonly observed in microarray gene expression 
data (see Figure 6). We designed caCORRECT to have several advanced features: (1) to 
uncover significant, correctable artifacts that affect reproducibility of experiments using 
data visualization and image processing techniques; (2) to improve the integrity and 
quality of public archives by removing artifacts; (3) to provide a universal quality score 
to aid users in their selection of suitable microarray data for new experiments. All of 
these features make microarray data more reproducible and thus more interoperable by 
making data sharing more successful. caCORRECT is freely available for on-line use at: 
http://cacorrect.bme.gatech.edu. caCORRECT already has many active users worldwide, 
including at Georgia Tech/Emory University, North Carolina State University, Louisiana 
State University, University of Hong Kong, and University of Essex. 
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Importance of Microarray Experiments for Medical Research 
One of the earliest applications of gene expression microarray data to human 
medical studies was an effort to subtype two kinds of leukemia [41]. For microarrays to 
reach their full potential as a clinical molecular profiling tool for personalized and 
predictive medicine, the quality of microarray data must be addressed. The FDA started 
the MicroArray Quality Control (MAQC) consortium and is seeking to develop FDA 
guidelines on microarray quality control and data analysis [42, 43]. However, the current 
status of microarray quality control and noise reduction is still a collection of scattered 
tools and methods. While tools such as dChip [44], RMAExpress [45], Harshlighting [46] 
and SmudgeMiner [47] include methods to improve the quality of microarray data, these 
tools fail in several important aspects: (1) they do not provide sufficient visualization to 
help a novice user understand the source of data problems; (2) they do not incorporate 
spatial information into the outlier detection methods; (3) they do not incorporate outlier 
information into their normalization routines; and (4) they do not generate dataset quality 
metrics to help users select high-quality data [48, 49]. 
To improve the quality of genomic data, it is important to understand the source 
of the errors and the current state-of-art in quality control. Recent studies have shown that 
the choice of microarray platforms is important, but not always the primary factor 
influencing data quality produced by laboratories. Instead, laboratory techniques are often 
responsible for the lack of reproducibility in microarray datasets [50].  It has even been 
suggested that some gene co-expression in microarray chips is the result of spatial 
artifacts—with the gene pair correlations being more a function of relative chip distance 
than chromosomal distance [51]. Even worse, the methods that are designed to alleviate 
such chip to chip non-uniformity could actually hamper results [52, 53].  Using 
caCORRECT’s capability for interactive visualization, we discover several classes of 
artifacts which can be easily linked to their root causes. Among the most common 
artifacts are scratches, edge effects, and bubble effects that manifest as visible localized 
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variations in the microarray dataset. These localized variations are not detected at the 
level of gene expression, but can be seen using low-level scanner outputs and by 
preserving the original spatial orientation of the microarray.  
Much work has already been done at the gene expression analysis level to detect 
outlier data points and to improve the reproducibility of microarray results. Affymetrix 
microarrays, for example, can be processed with Affymetrix’s own Microarray Suite 
(MAS5.0), GeneChip Operating Software (GCOS), or Probe Logarithmic Error Intensity 
Estimate (PLIER), but alternatives such as dChip [44], RMAExpress [45] or Guanine 
Cytosine Robust Multi-array Average (GCRMA) implementations in Matlab or the R 
statistical language (http://www.bioconductor.org) also exist. These programs include 
good measures such as normalization, background correction, and robust model fitting in 
an attempt to determine gene expression from multiple probe values. Many of them 
provide a visualization feature showing where outlier probes, or probe sets are located on 
the chips, but yet they do not include this spatial information in their outlier detection 
schemes. Direct comparisons of caCORRECT to these methods are difficult because 
caCORRECT is a quality assurance step happening before expression analysis, and with 
each of the methods mentioned above, noise removal and gene expression calculation are 
inseparable.  
One method by Reimers and Weinstein [47] does take spatial effects into account. 
This system can be used to visualize regional biases across high-density chips. Citing 
factors such as temperature, liquid flow rate, RNA diffusion rate, and edge effect, they 
showed that significant regional biases are common and can greatly affect downstream 
results. In addition to localized background calculation, Reimers and Weinstein’s 
program produces a comprehensive quality score for each chip by measuring the 
correlation of each probe’s expression level to that of its neighbors. While this 
application may provide quality score information, it does not allow correction of these 
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artifacts. Users are then faced with a difficult choice to abandon a chip, or to proceed 
knowing that artifacts exist. 
In the development of new methods for quality control and assessment, Brodsky 
et al. proposed a novel method of using clustering of gene expression profiles across 
microarrays to indicate quality [54]. First, gene expression profiles are clustered, and then 
the uniformity of the clusters’ distributions across the microarrays are measured. Second, 
the patterns of high and low expressed genes are monitored on each sample for 
uniformity. These two methods provide a dual description of a gene’s artifactual nature, 
which is then used to discard it from further analysis. Most of the genes discarded in this 
way are identified as a result of artifacts localized to one or few chips. Brodsky’s strategy 
of removing such a gene from the experiment entirely is too harsh, and therefore 
caCORRECT uses the more conservative strategy of removing offending gene data from 
the specific chips which contain the artifacts. In this way, caCORRECT is able to retain 
all genes on the array while removing potentially distracting noise.  
A brief survey of current microarray databases (e.g. Gene Expression Omnibus 
(GEO) [55], arrayExpress [56], caArray [57], Center for Information Biology Gene 
Expression Database (CIBEX) [58, 59], and Standford Microarray Database (SMD) [60]) 
reveals that quality analysis at this level of detail is beyond the scope of many labs which 
produce microarrays today. The post processing done by labs corresponds to the goals of 
their experiment. Some labs produce technical replicates in hopes to increase signal-to-
noise ratios and to reduce the need for laborious artifact detection, while others just 
ignore these effects and look only at large-scale data features. For data curators and data 
consumers (who often only have access to the published expression data, and not to the 
more detailed output of the scanner), a different approach is needed. Our goal in 
designing caCORRECT is to make public data a knowledge resource for the whole 
community, and let goal-oriented researchers with more detailed goals use data at a level 





Figure 6: caCORRECT Interactive Mode Screen Shots. These are two examples of the 
caCORRECT interactive mode interface under normal use. The default configuration is 
on top. Clicking on the switch button (two opposing arrows) produces the image at the 
bottom with the enlarged histogram plot. The color stripes in the histogram plot 
correspond directly to the color bands used in the heatmap. The histogram panel can 
display the distributions of variance score (shown), original intensity values and 
normalized intensity values. 
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System Overview 
The caCORRECT workflow (see Figure 7) centers on detection and removal of 
regions of probes causing localized chip variances (a.k.a. artifacts). The defining feature 
of an artifact is that it clearly results from errors in microarray manufacturing or lab 
processing, and not from the underlying biological state being measured. The first step in 
the caCORRECT workflow is a modified quantile normalization process to align the 
distributions of each uploaded chip and remove global chip biases. Following this step, 
variance scores are calculated to analyze data quality on a probe by probe basis. Next, 
image processing is run on the variance data to identify artifacts. At this point, quality 
metrics are calculated describing the artifact coverage and noise content of each chip and 
of the experiment as a whole. Outlier detection is an iterative process because many small 
to medium artifacts are over-shadowed by larger artifacts in earlier rounds, but become 
detectable once the data is renormalized using the artifact-aware process. 
  Upon completion of caCORRECT, the user is presented with the following files: 
1) heatmap images of all of the chips, with and without artifact masks, 2) new versions of 
‘clean’ probe expression files with appropriate data replacement, and 3) gene expression 
value tables calculated by the Bioconductor implementation of PLIER using data before 
and after caCORRECT. Figure 6 shows an example of caCORRECT’s interactive 
interface, developed to help the user understand how the variance calculation and artifact 
detection works. Most users prefer the automated batch mode after their first experience 
with the tool. In batch mode, the entire process of artifact removal runs without input 
from the user. 
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Figure 7: caCORRECT Workflow Diagram. The core workflow components include 
Quantile Normalization, Variance Calculation, and Artifact Detection. The automated 
mode runs all steps up to replacement, while the interactive mode allows users to adjust 
parameters, remove problematic chip files, and update results. 
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Heatmap Generation 
The heatmaps provided by caCORRECT serve to aid the user in validating the 
results of the system, as well as to see and learn about the nature of the artifacts in the 
data, and perhaps to take steps (e.g. updating lab protocols) to avoid recreating these 
mistakes in the future. Heatmaps are created by applying a threshold to the variance score 
(roughly the 80th percentile for scores.) This threshold may be adjusted in interactive 
mode, to make the system more or less sensitive to variance. Any variance value above 
that threshold is automatically assigned to the ‘hottest’ heatmap color. This color 
indicates data that will activate artifact detection when it is concentrated to regions on the 
chip.  
For a microarray chip containing reliable data (unadulterated by experimental 
protocol errors), these hot spots will represent real mRNA concentration differences in 
the experimental sample. Modern layout techniques for microarrays ensure that these 
spots will be distributed randomly throughout the chip. In many cases, however, 
protocols do not achieve uniform hybridization due to uneven drying, formation of salt 
streaks, scratching or contamination of the microarray surface due to contact with skin or 
dust, miscalculated hybridization times, or failure to control environmental variables 
[61]. All of these most common mistakes result in clearly visible localized patches of 
high variance (a.k.a. artifacts) on the heatmap. 
Data Quality Scoring 
A major goal of the caCORRECT system was to describe experimental datasets 
and chips according to comparable quality scores. The desired properties of a quality 
score for microarray experiments are as follows: (1) If chip variation between technical 
or biological replicates is low, the quality score is high; (2) the quality score of an 
experiment composed of identical chips is maximum; (3) The quality score should be 
bounded for easy comparability (e.g. [0,1]); (4) Masking of high variance regions from 
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the scoring algorithm should improve quality; and (5) the ordering of the chips should not 
affect the quality score. Our efforts have produced two balanced scores: the Uniformity 
Score (described below) and Artifact Coverage Percentage. 
For the Uniformity Score, we implemented a pairwise Normalized Cross-
Correlation (NCC) algorithm that satisfies all of our desired properties. The score gives 
feedback to a lab which is generating microarray data as to the quality and repeatability 
of their own work. It also gives users of public microarray data repositories some criteria 
by which to select a dataset. In addition to this uniformity score, we calculate an artifact 
coverage percentage during the artifact identification process for each chip, and for the 
dataset as a whole. This number can be used to remove highly suspect chips from the data 
set to improve analysis results. These scores are easily integrated into one overall score 
by averaging uniformity score with 1-Artifact Coverage and are converted to a scale from 
0 to 100 for easier interpretation. It is recommended that any chip with an overall score 
less than 80 (roughly 25% artifact coverage) be considered for removal from the dataset, 
especially if the artifacts are widespread and diffuse in nature, as opposed to a sharp, 
localized artifact that is easily removed. 
Artifact Detection and Artifact-Aware Gene Expression Calculations 
Perhaps the most obvious benefit of this tool is the identification and replacement 
of artifact-flagged data before they can foul downstream results. caCORRECT 
accomplishes this by sending its own heatmaps through a battery of image processing 
routines which are designed to identify spatially relevant areas of high variance. The 
image processing routines can vary from relatively simple moving-window searches used 
in batch mode to complex custom-designed kernels used in interactive mode to find 
specific artifacts based on user input.  
To maintain the specificity of artifact removal during interactive mode, we require 
that users provide minimal information or parameters regarding the type, size, and 
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location of probable artifacts present on the chip image via a simple point-and-click 
interface. Based on the artifact type and size suggested by the user, an image kernel 
(mask) is generated. Simple morphological convolution is then applied to the chip 
heatmap image based on the custom kernel.  Depending on the type of artifact being 
identified, various open and close operations are then performed to further specify the 
artifacts. Once identified, these identified artifacts may be superimposed on the original 
chip image for visual comparison by the user. Flagged spots already indicated by 
proprietary software provided by Affymetrix encoded into the CEL file format can also 
be superimposed on the image for comparison during the artifact flagging process. In 
most cases, we have found that outliers specified in CEL files do not correspond well to 
our artifact definitions, but are more randomly distributed throughout the heatmap. The 
user has the option of retaining these outlier indexes, or replacing them upon data 
retrieval. 
Aside from visual inspection, we suggest data quality metrics (discussed later) as 
a quantitative measure of the completion of the artifact removal process and resultant 
chip quality. The user may accept the identified artifacts at any time, or repeat the artifact 
removal process iteratively until they are satisfied.  
Once the user is satisfied that the artifact removal is complete (or at the end of 
batch removal) the data may be retrieved by the user with the artifact-flagged data 
appropriately replaced. The most common methods are to replace individual probe 
intensities with the mean or median values of that probe for each non-artifact sample in 
the dataset. Besides these options, caCORRECT also allows replacement with zeros, with 
‘null’, or any other custom value that the user prefers. 
Quality Assessment of Public Data 
Our artifact removal strategies were validated against real data from the scientific 
literature. We selected recent experiments from ArrayExpress and Oncomine with 
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available Affymetrix CEL and an associated publication. Our results (see Table 1) show 
three interesting trends. First, the yeast genome chips produce data of overall higher 
quality than the human microarrays. These chips also represent the most recently 
acquired data. Second, in cases where artifact coverage is the greatest, the improvement 
in quality score due to running caCORRECT is also the greatest. Finally the quality score 
corresponds well to predicted similarity of the biological samples. Separating chips by 
class produces the highest quality scores when the classes are the most uniform (wild-
type yeast and healthy lung tissue) while samples of low uniformity (modified yeast and 
tumor samples) are generally of lower quality. 
 













YG_S98 Yeast NOS stress – All 
[62] 95.15 95.817 20 2.35%
  Wild-type only 97.368 97.613 12 3.60%
  Other Types 92.382 94.347 8 4.75%
Oncomine HU6800 Lung Carcinoma – All 
[63] 91.577 93.441 98 3.88%
  Tumor Class I 90.393 92.878 67 4.36%
  Tumor Class III 91.187 92.842 19 5.55%
  Healthy Lung 97.711 98.007 10 1.64%
Oncomine U95Av2 Breast Carcinoma – All 
[64] 92.076 92.531 89 1.30%
  High-risk 92.231 93.148 18 3.27%
  Low-risk 91.482 92.258 19 1.87%
  Recurring 91.483 91.882 18 1.65%
  Non-recurring 91.799 92.498 34 1.63%
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Extension to New Affymetrix Platforms 
By design, caCORRECT can support any chip scanned on the Affymetrix 
platform that produces CEL files in their standard formats. However, to ensure that 
caCORRECT stays current with the latest chip designs, it was tested with two new types 
of chips from Affymetrix. One is the HG_HT_U133B, which is designed for running 96 
samples in one scan. I encountered these chips while analyzing the Connectivity Map 
dataset from the Broad Institute at Massachusetts Institute of Technology. These chips 
are automatically recognized by the software, but interpreting the resulting artifact 
locations is more difficult because there are many more control regions in the chip.  
The second type of chip was provided by the Affymetrix HapMap Project for 
Genome-Wide Association Studies (GWAS) [65-67]. These new Genome SNP chips are 
much, much larger than previous chips. They measure up to 1,000,000 single nucleotide 
polymorphisms (SNPs) and are generally considered to be a more robust use of 
microarrays than those developed for gene expression. These new chips are rectangular 
rather than square. Luckily, all of our algorithms were developed to deal with rectangular 
chips. Table 2 shows the advances in scale presented by these new chip platforms. 
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Table 2: Relative sizes of new chips supported by caCORRECT. 
Dataset Name Connectivity Map 
Build 2 
Dr. Andrew Young 
Renal Fixed Tissue 
HapMap  
Chip Platform HT_HG_U133B X3P (biggest 
processed to date) 
GenomeWide SNP 
v6 
Dimensions 744 x 744 1164 x 1164 2680 x 2572 
Total Intensity 
Measurements 
553536 1354896 6892960 
Percent Increase 
Over Previous 
 244% 508% 
Number of 
Experiment Samples 
6029 24 270 
Typical Quality 
Score 
90 72 75 
 
This rapid change in the scale of data sets for processing was anticipated in the 
research plan for caCORRECT. However, certain infrastructure improvements and 
optimizations were required as chips doubled and then quadrupled in size. These 
improvements include: 
1. Migration of the entire code base to a 64-bit test and production server 
(named Hercules and Gaia). This allows the software to surpass the 4GB memory limit of 
32-bit machines. The new memory limit is now 16GB. 
2. Conversion of intermediate data files from ASCII text to binary formats. 
This makes debugging more difficult, so utilities were developed to readily convert 
between the two formats, and all processes can switch between the two. 
3. Transition from the Bioconductor-based PLIER implementation to our 
own custom gene calculation method (called TAXY, or Theta Alpha X Y Regression).  
PLIER does not support the exclusion of artifact-flagged probes from the gene 
calculations. This meant we had to use median replacement of artifact probes as a pre-
processing step to the gene calculations. The R implementation of PLIER also did not 
scale very well to datasets of large sample size, mainly because of memory management 
limitations. The combination of these two factors made the gene calculations step the 
largest contributor by far to the run time of our processes. Our newly-developed method 
is significantly faster (a factor of 10x) and uses memory more efficiently (by loading each 
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probe set one at a time). This new algorithm is called TAXY and was developed by 
Richard Moffitt and Weiguang Wang. 
Integration with ArrayWiki Community Repository 
The full caCORRECT quality control and analysis pipeline is run during the 
ArrayWiki import process. The variance heatmap and artifact mask images are displayed 
on the main experiment page. The quality scores are also available in the table of samples 
on the main experiment page. The original expression calculations can be downloaded 
from the experiment information box and the “clean” expression calculations are also 
available. Clean expression data are either median-replaced artifacts run through PLIER 






Figure 8: New chip platforms supported by caCORRECT. (A) Example of a 
caCORRECT variance heatmap for a high-throughput gene array from Affymetrix. (B) 
Example of a caCORRECT variance heatmap of a HapMap SNP chip with a significant 





ARRAYWIKI FOR COMMUNITY-BASED INFORMATION 
MANAGEMENT 
This dissertation describes a platform for Translational Biomedical Informatics 
(TBMI). ArrayWiki is the centerpiece of this platform. Not only does ArrayWiki display 
the results of running caCORRECT for thousands of experiments, but it also serves as a 
repository for all microarray-based analyses run in our laboratory. The Wiki framework 
natively supports the visualization technologies described in Chapter 4, so those features 
will be associated with their associated experiments. Although the design factor of 
adaptability maps most clearly to the third objective of translation, it is important to begin 
the discussion of adaptability here because the flexibility of the Wiki framework is ideal 
for uniting a research community around a single technical topic. In this way, ArrayWiki 
is also a step toward translation, though it is too focused on microarrays to ever achieve 
the impact that caBIG tools will have. This chapter is based on the publication of 
ArrayWiki in BMC Bioinformatics [68]. 
A survey of microarray repositories reveals that their contents and data models are 
heterogeneous, and that repositories developed for different communities have become 
“silo-ed” over time. Bioinformaticians have difficulties in finding datasets based on 
technical parameters rather than keywords. A community maintained resource, 
ArrayWiki, resolves these problems by uniting disparate meta-data that are difficult for 
users to find. This resource provides users with simple text-based searches across all 
experiment metadata, and exposes data to search engine crawlers (Semantic Agents) such 
as Google to further enhance data discovery. In addition, automated quality control 
processes provide extra information about data quality not available in other microarray 
resources. The data in this resource are open to community contribution, comment, and 
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modification, and are distributed and visualized using a novel, compact data storage 
format, BioPNG. ArrayWiki is available at http://www.bio-miblab.org/arraywiki. 
Adaptability 
Adaptability ensures that when opportunities arise for a service to be used in a 
different scenario, the architecture will not require major modification to suit the new 
circumstances. Making each piece of the design modular and using common standards to 
represent inputs and outputs to each module is the primary way to achieve adaptability. 
Thus, adaptability and interoperability are fundamentally related. Adaptability may be 
measured by the useful lifetime of a software product. 
Adaptability also includes the ability to upgrade the infrastructure under a service 
without adversely affecting its availability. Web services allow this flexibility by well-
described, robust methods of distributing HTTP requests among clusters of server 
computers. Individual servers can be taken off-line for hardware upgrades as long as the 
remaining servers can handle the expected increase in load. Improved up-front system 
design does not guarantee performance because of the unpredictability of user load in a 
distributed environment.  
Background on Large-Scale Integration Efforts 
As shown in Figure 9, current bioinformatics integration projects vary widely in 
respect to scale and in application of each of the three design factors described above. 
Based on the failure of unification projects, such as the Integrated Genome Database 
project [21, 69], most bioinformaticians now agree that distributed solutions are the most 
likely to succeed on the long term. This has resulted in most projects having the common 
ground in their selection of basic interoperable technologies. This dissertation presents 
three well-known bioinformatics integration systems, each mapped to a design factor: 
myGrid [70] is presented here, Genome-Phenome Superhighway (GPS) OmicBrowse 
[14] is presented in chapter 4, and caBIG [71, 72] is presented in chapter 5. 
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MyGRID 
Of the integration efforts designed to improve adaptability of bioinformatics tools, 
BioMOBY and Taverna myGrid [73] represent the grass-roots efforts. All integration 
projects depend on voluntary participation by the many bioinformatics labs around the 
world. BioMOBY [74, 75] took the voluntary aspect one step further by allowing service 
providers to define data types for the inputs and outputs of their services. BioMOBY 
consists primarily of a central registry of services (called MOBY Central). Each service 
entry in the registry contains lists of input and output object types, a URL, and a 
description of the service type. Along with this comes a library of data structure 
templates (MOBY Objects) and two hierarchies, one for data structures and one for 
services. Each of these three resources is completely open for modification by the 
scientific community. 
Taverna is workflow-building software linked with the myGrid vision. It is one 
example of a class of bioinformatics tools centered centered around task composition 
[76]. The workbench screen makes a default library of web services available. There are 
also mechanisms for searching for additional web service registries or importing web 
service descriptions found independently. Web services from the library can be dragged 
onto a workflow diagram and connected by specifying data interfaces. Using this tool, 
bioinformatics researchers can experiment with connecting various tools together into 
bigger and more feature-rich applications. Software developers can explore the value of 
integrating services and address certain unexpected data interface issues before beginning 
the user interface design process. Like caBIG, the acceptance by the bioinformatics 
community of this architecture is evidenced by the efforts of other groups to extend the 





Figure 9:  Summary of Strengths of Existing Large-Scale Integration Projects. 
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Community-Based Data Maintenance: ArrayWiki 
The result of our quality survey of public microarray data is being deposited into 
an innovative Wiki system, ArrayWiki, for public access and community modification. 
The creation of ArrayWiki necessitated a novel data format, BioPNG, which adds 
visualization, portability, and quality information in addition to compression.  
Previous surveys of microarray repositories reveal that their contents and data 
models are heterogeneous, and that contents of repositories developed for different 
communities have diverged over time. We have identified three usability problems with 
existing repositories. First, bioinformaticians have difficulties in finding datasets based 
on technical parameters (e.g. chip scan date) rather than biological keywords because 
most repositories are queried using a “literature search” paradigm. Second, when 
performing meta-analyses on microarrays (e.g. merging datasets, re-assigning biological 
classes, or removing low-quality chips), there is no community resource for storing new 
results linked in an intuitive way to the source data. Third, when merging data from 
different sources for comparative studies or to increase statistical significance, the 
maximum level of detail is necessary to standardize protocols and minimize bias from the 
separate data sources. 
We developed ArrayWiki to address these problems. The data in this resource are 
open to community contribution, comment, and modification, and are distributed and 
visualized using a novel, compact data storage format, BioPNG. Domain scientists can 
make a significant impact in this community by making a small investment of time to 
learn the syntax and structure common to all sites running MediaWiki software, and 
contributing to this knowledge base. ArrayWiki is available at http://www.bio-
miblab.org/arraywiki. 
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Comparison to Existing Public Microarray Repositories 
ArrayWiki was the result of studying the strengths and weaknesses of existing 
microarray data repositories (see Figure 10). These include Gene Expression Omnibus 
(GEO) [55, 78], ArrayExpress [56], caArray Database [79], Stanford Microarray 
Database (SMD) [49], and oncoMine (OM) [80, 81]). This is only a sampling of the 
many online gene expression repositories, but GEO and ArrayExpress are the largest 
repositories by far. More recently, a group from University of California, Los Angeles 
published Celsius [82], an effort to merge all Affymetrix data from disparate repositories 
into one location, available through a single programmatic interface. The Celsius authors 
support the importance of this work for three main reasons: the microarray repository 
field became very fragmented, data at the CEL file level is difficult to find even in the 
largest repositories, and experiments are annotated inconsistently across repositories.  
All of these databases represent important efforts for ensuring that resources spent 
on microarray experiments are not lost, but are preserved for future generations of 
researchers [53]. However, most of these databases fail to provide any chip quality 
information. Also, they do not offer a familiar Wiki interface for community data 
curation without using a programmatic interface. Finally, none of these repositories have 
made a noticeable effort to include the Affymetrix DAT file type in their experiment 
records. The DAT files available in ArrayWiki offer the highest possible detail level 
about public experiments and allow bioinformaticians to more deeply explore data 
quality and improvements on the algorithms used by Affymetrix software (see Figure 
11). ArrayWiki is not intended to replace these public repositories of data, but will 
augment the information they contain with information provided by novel algorithms 
(caCORRECT) and by the community. 
Figure 12 depicts the overlap in experiments between four popular repositories. A 
standard procedure was used to generate this figure. All datasets examined were public, 
and had submission (or release) dates between August 2005 and June 2006 inclusive. 
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Each dataset was searched in every other database using no date criteria. The criteria for 
determining matching datasets were species, platforms, authors, affiliation and 
publication (if available). This was repeated for each database.  Our interpretation of 
Figure 3 is that repositories developed for different communities have become “silo-ed” 
over time. The majority of experiments are found in only one repository 
(1358+528+10+7=1903 or 80%). Experimenters tend to patronize a particular repository, 
and the only evidence of an effort to merge repositories with the purpose of facilitating 
large-scale data mining is the incorporation of SMD experiments into ArrayExpress and 
GEO at certain points. This means that bioinformatics researchers must search all 
repositories to ensure they’ve collected all public data relevant to a particular topic. 
Finally, despite the cost of obtaining tissue samples and the complexity of 
analysis and interpretation, human and mammalian chips still outnumber all other sample 
organisms (e.g., cell lines, plants, and single-celled organisms). This statistic may be 
inflated by the failure of many repositories to distinguish between samples taken directly 
from human tissues and those from genetically modified human cell lines. 
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Figure 10: Comparison of microarray repository contents. The relative size of each pie 
corresponds to the size of each repository. Key observations include that SMD does not 
contain much recent data. One data artifact is found in the caArray Yearly Breakdown. 
An abnormal number of experiments show a date of ‘1-1-2000’ because that is the default 
and the validation is not adequate. 
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Figure 11: Diagrams showing the loss of data and precision during microarray 
processing. * Electron microscopy image of a microarray (adapted from reference [83]). 
 
 
Figure 12: Venn diagram showing overlaps in experimental data between repositories. 
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Usability of Existing Repository Interfaces  
Designing easy-to-use and clean interfaces to assist data providers and data 
consumers to upload and download is critical for expanding the reach of microarray 
repositories. However, the usability of existing repositories is harmed by a lack of shared 
standards for providing minimally required experimental data.  
First, existing repositories have different requirements for data submission, and 
vary in their degree of openness to community involvement. These repositories vary in 
their ease of use of human interfaces (e.g., web sites), in the availability of programmatic 
access through Application Programming Interfaces (APIs) and their availability of data 
for bulk download (e.g., the entire database available through file transfer protocol (FTP) 
or export of search results in Extensible Markup Language (XML) format). In general, 
GEO and ArrayExpress have good web sites and APIs, but any effort to merge their 
datasets (as in ArrayWiki) requires developers to learn a variety of interfaces (Custom 
XML and SOFT files for GEO, MAGE-ML and seven custom file formats for 
ArrayExpress). Being the earliest developed repository, SMD does not make use of 
recent advances in usability such as JavaScript and AJAX. However, its functionality has 
been updated over time based on feedback from users and thus is far better than caArray, 
which is slow to respond and does not provide advanced search functionality.  
Second, the existing repositories have different policies with regard to the 
timeline of making uploaded data available for public consumption. In some cases, this is 
a service to authors to allow them to use processing tools while keeping data private until 
publication. For example, GEO’s express policy is to make data public automatically 
after six months. Existing repositories also have different data verification and curation 
because the database administrators vary. Some repositories will exchange emails with 
individuals making submissions to check facts. Regardless, at the detailed level of raw 
probe data, many problems still make it into the final repository, including corrupt file 
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formats and missing probe intensity files. Many experiment records claiming to include 
200+ chips may only contain half that many files in the associated compressed data file.  
Finally, the existing data repositories do not provide scanner intensity data, even 
though this data is extremely useful for quality control procedures. This data type absence 
certainly confounds down-stream data analysis because the artifacts caused by instrument 
and experimental procedures cannot be double-checked by the users.  
Data Maintainability of Existing Repositories 
Meta-data in existing repositories are usually problematic due to lack of standard 
in data maintainability design. One category of problem is the lack of meta-data. Most of 
the repository query interfaces are optimized for finding specific experiments from the 
literature, which is the first step taken by clinicians or biologists. (Based on the 
comparison survey we conducted, connections between experiments and PubMed are 
usually accurate.) However, they often do not provide technical features, i.e., meta-data 
such as number of samples, quality control measures, and probe-to-gene conversion 
methods (e.g. GCRMA or PLIER in Affymetrix technology). These features are critical 
for the downstream gene ranking and interpretation.  Also, they often fail to provide and 
the correct dates of the experiments, and the associated protocol information. For 
example, some inaccuracies are a minor nuisance, like an experiment in SMD performed 
by Hong Juan on 11-16-1001 (instead of 11-16-2001), but others are more serious, like 
the problem in caARRAY where default experiment dates are all set to 01-01-2000, 
making that appear to be a wildly popular day to run a microarray experiment.  
The issue of assigning an experiment date is unresolved in itself. Most microarray 
experimental results use arrays processed over a period of weeks, months, even years in 
some cases. When a data provider is expected to provide that field, they often just enter 
the publication date of the final paper. This is completely different from the timestamp of 
the data in the original arrays (e.g., the Affymetrix intensity data format contains a 
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timestamp that the array was scanned). Until now, no microarray repository has 
attempted to extract and provide that data. 
Another category of problem is the lack of adaptability of meta-data. That is the 
adjustment of meta-data based on the evolution of Microarray data standards. Before 
widespread adoption of the MGED Object Model (MGED-OM), microarray repository 
designers were left to invent their own labels for each column in their database. This led 
to a lack of agreement in what is appropriate to make a required field, and what meta-data 
(data labels) make the most sense to users. caARRAY is the only repository based 
entirely on MAGE-OM standards, but it’s impossible to map experiments to their meta-
data using the current search interface. Based on all the issues discussed above, we design 
and develop a Wiki repository that can evolve meta-data standards at a rate the 
community demands. 
Methodology and Development of ArrayWiki 
An important consideration when creating a biological data repository is the reuse 
of data standards accepted by the community. However, there are only nascent efforts 
underway to standardize human curation interactions with data repositories [84]. Every 
repository still develops custom interfaces (usually web pages) for data access and 
modification. Technical experts might take the time to learn a specialized curation tool, 
but the wider community is unlikely to invest the time and effort. For this reason, the 
most difficult part of hosting a repository is recruiting and maintaining the interest among 
domain experts to contribute information and validation. The policy of many repositories 
of only allowing original data providers to modify their records adds to this problem  (see 
Figure 13). The result is that while data is becoming increasingly sharable, it is also 
becoming increasingly stale [20].  
The Wiki paradigm will likely be an important technology for data curation for 
biomedical research [85, 86]. Inspired by the spectacular success of the Wikipedia project 
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(http://www.wikipedia.org), there have been efforts to compile biological knowledge in a 
Wiki format [87-89]. Also, there have even been suggestions that the whole of medical 
knowledge may one day be accessible through this format [90]. These efforts are largely 
motivated by the ease of use of Wikis and the ready availability of high quality, free and 
open source wiki software, such as MediaWiki (http://www.mediawiki.org). Wikis 
provide readable information for both humans and computer programs (see Figure 14 and 
15). In fact, recent publications have already shown that semantic web technologies such 
as automated annotation using Wikipedia pages have had some successes [91].  
System interoperability efforts such as MAGE-OM [92], SBML [93], BioPAX 
[94, 95], and caBIG [96] rely on XML for machine readability. However, translation of 
XML into human-readable format is not a trivial process. The dbpedia effort 
(http://dbpedia.org/docs) is an open source project with the goal of automatically 
translating Wikipedia entries into the Resource Document Framework (RDF) format, 
which is a more recent and more flexible technology based on XML for Semantic Web. 
The Wiki syntax does not have a standard parsing structure like XML. However, the use 
of a smaller vocabulary of formatting syntax and “templating” improves the machine 
readability of its contents over that of typical unstructured web contents.  
Wikis hold their greatest promise in the dramatic advances over XML in human 
readability. Future research may be able to fully integrate human-readable (Wiki) and 
machine-readable (XML) technologies [97]. Many users have the opportunity to modify 
Wiki data, and eventually consensus can be reached naturally. Many standards bodies 
(e.g. the SBML Consortium) already use Wiki software to accept community input before 
freezing a specification document. The BiomedGT Collaborative Ontology Development 
Wiki was designed by the National Cancer Institute to facilitate development of new 
ontologies with input from the wider community. They are currently working on many 




Figure 13: Evolution of biological data repositories (microarray case study). The 
capabilities of data consumers and data providers have changed over time. ArrayWiki 
represents the most open model, where all users can update data annotations and 




Figure 14: Sample experiment page in ArrayWiki. General experiment information such 
as contact info, data download links, and experiment summary are at the top. A table of 
samples at the bottom provides quality details and links to information about each 
individual sample, including BioPNG images of standard deviation data and scanner data. 
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A.      
 
B.   
 
Figure 15: Detailed look at components of the experiment page. A) Representative 
experiment header in ArrayWiki. B) A close-up of two chips on the main experiment 
page with differing artifact patterns and quality scores, although they were processed in 
the same lab within 2.5 hours of one another. Meta-data uniquely available in this 
resource are the sample class assignments, quality scores, chip variance and artifact 
visualizations, scan dates and times, and visualizations of the NPIXEL and STDEV 




In view of the limitations of repositories closed to community maintenance and 
the valuable features of Wiki knowledge repositories, we have developed ArrayWiki to 
host microarray data in an open environment, modifiable by any user. The culmination of 
ArrayWiki might be to unite data from other repositories, while providing the most 
detailed raw data and results of the latest best-of-class analysis algorithms.  
ArrayWiki pages are initialized programmatically by accessing APIs of GEO and 
ArrayExpress, or manually when an experiment does not exist in any repository yet. The 
current version contains over 650 experiments imported by GEO API (see Table 3). 
Quality control processes are still being run on these experiments to complete the import. 
A local database listing of all imported experiments ensures that existing pages are not 
overwritten each time the import process runs. A PHP class called Snoopy allows the 
import program to manipulate Wiki pages using HTTP POST, mimicking the process by 
which human users add contents. This is better than direct insertion into the database 
because it preserves the page history and the update tracking system, allowing for 
rollbacks of unintended changes.  
ArrayWiki makes use of many useful add-ons to the MediaWiki software to 
enhance security and interoperability of data. One of these add-ons is the Captcha graphic 
for reducing automated spam generation. This feature requires the user to type a 
nonsensical word displayed in an image file whenever they add external links to a wiki 
page. Another add-on is the email image convertor. Contact emails are displayed as 
images in ArrayWiki to prevent mass harvesting of emails by automated scripts. We are 
considering a polite automated process that will ask data providers to update their contact 
information and flag email addresses that are responsive as an additional indication of 
experiment quality. 
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In addition, the import process accesses raw data files and converts them to the 
BioPNG format (see Figure 16,discussed further in chapter 4). This efficient storage 
method allows our system to support a greater data load and to make more efficient use 
of network bandwidth for downloads. This format offers greater protection against 
malicious software than ZIP files (which may contain embedded executables). Custom 
scripts have been added to convert BioPNG files into the Affymetrix version 4 CEL files 
to enhance data interoperability. These files are temporarily made available for download 
by clicking the link and later deleted to conserve file system space.  
The import module of the ArrayWiki design is a multi-step process with many 
integration points and potential failure points (see Figure 17). We are continuing in our 
effort to make the process automated, especially detection of errors and error handling 
(e.g. splitting experiments that contain multiple chip platforms into separate Wiki pages). 
The import has been stress tested by importing 7029 microarrays from the Connectivity 
Map Batch release 2. Now, the seven steps of the import have been implemented as jobs 
(using the cron scheduler in Linux) that initiate every hour, allowing for as many as 24 
experiments to be imported per day. 
ArrayWiki runs a number of automated quality control processes during import 
and all results are stored on the page. In addition, the capture of novel meta-data allows 
for quality overview results as in Figure 18. It is recommended that users download 
“clean” data when available. The import program uses a standard Table or Infobox 
template for all meta-data to improve machine readability. ArrayWiki also uses templates 
(in the style of Wikipedia) that allow Semantic Agents like dbpedia to better interpret 
structured data. Over time, ArrayWiki may prove to be a useful tool for reaching 
community concensus on data specification and curation standards.  
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A.  
   
B.     C.              D. 
Figure 16: Examples of seucre BioPNG compression of Affymetrix CEL file data in PNG 
format. A. BioPNG distributes the components of a floating point numerical value into 
three color channels of a PNG image by first converting to binary representation and then 
splitting the string of bits into integer and decimal parts. The allocation of integer and 
decimal parts is determined by the precision required to store the data. The inverse 
relationship between CEL Intensity data and CEL Standard Deviation data causes the 
overall effect to be red or blue (B. and C.). This causes the data types, which might easily 
be confused when presented in text format to be immediately visually distinguishable. B. 
The Probe Intensity data file can also be used to verify problems such as edge effect. The 
original CEL files can be rebuilt using this file. C. The Standard Deviation data file gives 
a picture of scanner confidence in the measured values. Experimental protocol problems 
such as edge effect are usually seen here and support the variance heatmap. D. An 




Figure 17: ArrayWiki automated import process details. At any given time, 7-9 jobs 
could be running. All of the check-pointing of data integrity between steps is managed 
using the ArrayWiki database. The import process was designed to be parallelizable and 
currently runs on two independent machines, both connecting remotely to the same 
database and inserting text into the production wiki site. 
 
Table 3: Results of running ArrayWiki import over a period of six months. 
Property Value 
Total Experiments Loaded 675 
Experiments Attempted 1022* 
Number of Chips Loaded 20,025 
Data Sources (unique contact 
emails) 936 
Average Number of Chips per 
Source 26.7# 
Total Image Directory Size 68GB 
 
* Causes for failure include: corrupt data files, missing 
chip definitions, and sample size < 4. 
# Sample max of 200 may underestimate. 




B.       
 
Figure 18: Data quality features extracted using ArrayWiki meta-data. A. Histogram of 
16791 microarray samples in ArrayWiki database. The red line at quality score 80 
indicates the quality cut-off at which our team recommends discarding the sample from 
analysis. 1% of samples do not meet our quality requirements. Analysis using these 
arrays is seriously compromised. Most samples with quality scores between 80 and 95 
contain artifacts that can be corrected by caCORRECT. These samples often are not 
identified as problematic by traditional QC means. B. Comparison of how experiment 
time span is related to quality. Long-running experiments are much more prone to “batch 
effect” because of change-over in technicians running the microarrays and changes to the 




BIOPNG AND SCALABLE VECTOR GRAPHICS VISUALIZATION 
FOR BIOLOGICAL DATA 
Biomedical Informatics has experienced an explosion in data analysis tools in 
response to the dramatic growth of data described in chapter 1. The biomedical researcher 
from a non-computational background is somewhat bewildered by this array of tools just 
as they are by the task of data management. The third objective of this dissertation is to 
develop an interactive web-based visualization system that enables fast and effective 
biomedical decision-making by integrating various data sources and by visualizing 
heterogeneous data and information. This aim addresses challenges of enabling efficient 
access to information in a fast-paced environment. This aim can be measured by how 
well the technology improves usability of tools. The key metrics of usability for TBMI 
are accessibility through the web, flexibility in visual rendering, and responsiveness even 
when handling high-throughput data. The key contribution of this research is that it only 
uses technologies that allow for embedding of the complete source data for the 
visualization into the same file that provides the visual data. This facilitates sharing and 
verification of data in complex workflows. 
Biomedical data visualization is a great challenge due to the scale, complexity, 
and diversity of systems, interactions and experimental data. Standards for interoperable 
data are a good start to addressing these problems, but standardization of visualization 
technologies is an unsolved problem. SimpleVisGrid is a visualization system that builds 
on caBIG common infrastructure for cancer research, and clearly specifies and extends 
three standard data formats for inputs and outputs to the services: comma-separated 
values, Portable Network Graphics, and Scalable Vector Graphics. Four prototype 
visualizations are implemented: 2D array data quality visualization, correlations between 
high-dimensional data and meta-data, feature landscapes, and biochemical or semantic 
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network visualizations. The services and data model are prepared for submission for 
caBIG Silver-level compatibility review and can be integrated into automated research 
workflows. This work is in preparation for submission to the Engineering in Medicine 
and Biology Society conference. 
Usability 
Usability is the dominant design factor among the three discussed because it 
determines the usefulness of an integrated system and thus its impact on society (e.g. the 
scientific community and ultimately on patient health). Interoperability and adaptability 
increase usability, but also lend many practical advantages to the developers. Usability is 
the most easily overlooked by computational experts because it requires open 
communication with non-computational users to measure and improve. Usability also 
benefits from standardization, the most important catalyst for systems integration. 
Most users (e.g. biologists or clinicians) have not been trained in computational 
algorithms [98]. Even for users that do have training, usability will continue to be 
critically important in bioinformatics system design. Bioinformatics systems often 
present unexpected results, but time is required to ensure that these results were not 
caused by a software bug. When processed results do not have an obvious derivation, the 
user has two choices: to blindly trust the results (which can propagate bad science when 
results are misunderstood and misused) or to look for another tool which will return 
something more sensible.  
User acceptance is still a large obstacle for bioinformatics. One reason is that 
computational scientists do not place enough emphasis on the usability of their tools and 
underestimate the rather large time commitment required to install, configure, learn to 
use, and independently validate the results of their software. Possibly the greatest concern 
of biomedical researchers is the risk of system instability (PC crashes and resulting 
productivity loss) that accompanies any new software installation. In addition, many 
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computational tools overlap in functionality with established workflows because users 
typically develop their own non-computational solutions, only to search for a software 
tool after the manual process becomes unmanageable. 
If bioinformatics algorithm experts want to capture advanced user feedback, they 
need to give users a sense that their needs are the priority by adding very simple usability 
feedback systems. Also, they should adopt web-based system development as the 
platform because almost every user is now familiar with how web browsers work and 
how to troubleshoot basic configuration problems. Lastly, integrated system developers 
can enhance user acceptance by forming interdisciplinary teams to increase usability and 
reliability of the system. 
Usability Standards 
Even very recent usability studies in the bioinformatics field are often based on 
high-level qualitative analysis. Some methods are under development, but none have 
reached wide adoption [99, 100]. Usability research requires investigation into the user’s 
motivations for trying the system, how the user is rewarded for using the system, the 
culture of the user, the expectations that the user brings to the interaction including 
expectations for personalization of the experience, and understanding of the context in 
which the user is working.  
One of the key problems in creating motivating visualizations for biological 
research is related to this understanding of context. Users with different specializations 
want to see lower levels of detail for concepts that they understand and higher levels of 
detail for unfamiliar concepts. This problem is often addressed in web applications by 
providing summary text reports with hyperlinks behind many identifying fields. Today, 
new technologies for providing scalable, interactive graphics will allow web applications 
not only to be even more portable to mobile devices, but also more visually appealing as 
well. 
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Systems Biology Graphical Notation (SBGN) Standard 
Systems Biology Graphical Notation (SBGN) standard [101] is a collection of 
over 40 symbols for the presentation of biochemical reaction networks. This notation 
standard includes the ability to compartmentalize the model, to reuse logical blocks, and 
to represent ambiguous or poorly understood relationships in the model. The small circles 
attached to reaction species blocks represent single-site modifications such as 
phosphorylation. 
The purpose of having a graphical notation standard is to add rigor and 
consistency to diagrams that convey biological network structure. Once the community 
has adopted a standard such as SBGN, its use will become familiar to everyone and the 
time spent on interpreting published diagrams will be reduced. A comparison to 
electronic circuit theory is appropriate here, because the graphical notation used for 
digital circuits has allowed large teams of engineers to collaborate in order to design and 
troubleshoot today’s highly complex microprocessors. Most computational systems 
biology experts agree that this degree of complexity is the future for biochemical network 
models. 
Gene Ontology (GO) 
The Gene Ontology [102, 103] was originally designed to address the pace at 
which biological elements were being described relative to the pace at which they were 
being discovered through genome sequencing. Three ontologies were developed. The 
Ontology of Molecular Function describes what a gene product (a protein or a strand of 
RNA) does at the most fundamental biochemical level. The Ontology of Biological 
Process describes what a gene product does in the context of the biological objective. The 
Ontology of Cellular Component describes the location of the gene product within the 
cell. The gene product may not necessarily be a part of the makeup of the given 
component; it may simply be involved in an activity in the location described by a given 
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component. Most researchers refer to GO as the ontology of gene function, because the 
biological process and cellular component terms also support cellular function. 
GO is represented as a directed graph of relationships and has a very limited set of 
relationships, currently limited to ‘is a’ and ‘part of’. The visual representation of these 
relationships provides a very good picture of the context of each term in the ontology. 
However, these pictures can also be very misleading because there is no easy way to 
depict relative significance in the relationships between terms. Layout algorithms for the 
graphs are currently focused more on fitting the nodes into a given space than on giving 
spatial relationships some kind of interpretive value. GO might benefit by defining a 
degree of membership for each gene product to each term, which could help differentiate 
between primary, secondary, tertiary, etc. contributors to biological functions. 
An analysis of the number of terms defined in the Gene Ontology shows a 
decreasing annual growth rate, from 27% in 2003 to ~10% as of January 2006, and 
contains ~25,000 terms as of March 2008. This indicates that the ontology is becoming 
more stable and that tools making use of the terms grow more reliable. However, the task 
of mapping gene products (proteins or active RNA) to all of the appropriate functional 
categories has only begun. 
Performance Optimization 
Performance (a.k.a. responsiveness) is a critical component to the usability of 
software systems. It is important that computational technology is used properly to save 
time for the human user, rather than becoming a hindrance to efficient completion of their 
work. However, it is a rule-of-thumb in software that optimization should happen last, 
after all other user functionality issues have been resolved. Benchmarking modules for 
timing, profiling algorithms for CPU and memory consumption, and properly applying 
best practices for performance requires extensive knowledge of the underlying 
technologies and hardware architecture. We have applied these techniques to many 
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technologies, including Matlab, Perl, Java Servlets, PHP, Python and Ruby. Many web 
technologies, especially AJAX, Javascript, and SVG, have not matured to the point of 
standardizing best practices for performance. However, in the development of the web 
visualization tools presented here, we have conducted performance analyses of these 
technologies and apply those best practices that have been identified. 
Notable Previous Work in Biological Visualization 
Visualization of biomedical data encompasses a diverse set of domain specialties, 
computational platforms, algorithms, and invariant representations (i.e. symbols or 
glyphs). Data visualization improves the efficiency of the scientific research by speeding 
the discovery of hidden patterns that may indicate key scientific findings or quality 
problems in the data acquisition step that should be resolved before starting analysis. 
Additionally, many visualizations are intended to enhance clinical decision-making 
[104], and may be a critical accompaniment to the successful translation of new 
molecular data acquisition techniques to the clinic and the advent of personalized 
medicine. 
Attempts have been made to organize visualization efforts into classes of general 
problems: including network layout, clustering & correlation, and general images and 
plots (see Figure 22). The classification system presented here has already been reduced 
to visualizations of “non-tangible” data, and excludes a whole body of work focused on 
accurate representation of three-dimensional (3D) objects such as anatomical 
visualization and molecular conformation visualization. In general, the work of 
SimpleVisGrid has been to focus on the enormous field of two-dimensional (2D) data 
representation for interpreting data analysis results, with the minor exceptions of 
discussing the application of BioPNG to “data cubes” and the use of two-and-a-half-
dimensional (2.5D) representation used to view feature landscapes. 
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Visual Statistical Data Analyzer (VISDA) [105] is the first visualization tool to 
become Cancer Biomedical Informatics Grid (caBIG) certified. Cytoscape [106-108] is a 
general network visualization tool that has deservingly received a lot of attention in this 
field. Cytoscape is an open-source standalone installation and makes some APIs available 
for other developers, but does not support web-based or grid-based requests. Haploview 
[109] is useful for comparisons of entire genomes to one another to look for small 
differences. GeneWindow [13] is an interactive Scalable Vector Graphics (SVG) 
interface that enables the user to browse gene sequences with a variety of annotation 
overlays. Matrix2PNG [110] is a simple and useful tool for quickly converting data 
stored in a matrix into a heatmap. There are some similarities between Matrix2PNG and 
the BioPNG system presented here. The primary difference is that BioPNG can be used 
for data transport. It always treats the encoding of data into a PNG as a potential two-way 
interaction, sacrificing some of the visual appeal of the graphic for the ability to retrieve 
the original data using only the BioPNG file. 
Genome-Phenome Superhighway (GPS) OmicBrowse 
The Genome-Phenome Superhighway (GPS) OmicBrowse [14] is a web-based 
genome visualization tool developed by the RIKEN Genomic Sciences Center in Japan. 
The tool is web-based, so there is no need to install or upgrade local software. GPS is 
integrated with 12 databases and provides text search on all of them simultaneously [15]. 
This tool demonstrates a focus on usability as every result is translated into a location on 
the genome of the selected species. Four species are currently supported. 
The primary drawback to OmicBrowse as an integrated tool with wide appeal is 
that the interface was developed on a proprietary platform (Macromedia Flash, now 
owned by Adobe Systems, Inc.). For this reason, the connections to the back-end data 
servers are obscured from user inspection, so data currency is difficult to verify (recent 
visits to the GPS website indicate that this problem may have been overcome as this 
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group has made their software and database backend freely available for download). 
Additionally, the visual components cannot be incorporated into a larger suite of tools 
except as a complete package, forcing other bioinformatics groups to duplicate effort in 
order to implement genome browsing on a more open platform. Open standards now exist 
to improve the portability of visualizations. 
Database for Annotation, Visualization and Integrated Discovery (DAVID) 
DAVID [12] provides a set of data-mining tools that systematically combine 
functionally descriptive data with intuitive graphical displays such as interactive 
biochemical pathway maps, protein functional domain charts and Gene Ontology charts.  
DAVID is hosted at the National Center for Biotechnology Information (NCBI) at the 
National Library of Medicine of the National Institutes of Health. A user session in 
DAVID starts with uploading a list of differentially expressed genes from a microarray 
experiment. DAVID then connects to a number of public annotation databases to create 
an annotation summary, including: 
1. GenBank - Accession number corresponding to the nucleotide sequence 
2. Unigene - Cluster containing sequences that represent a unique gene 
3. LocusLink - Unique and stable identifier for curated genetic loci 
4. RefSeq - Reference sequence standards for mRNAs 
5. Gene symbol - Official gene symbol included in the Locus Report 
provided by NCBI 
6. Gene name - Official gene name included in the Locus Report provided by 
NCBI 
7. OMIM - Catalog of human genes and genetic disorders 
8. Affymetrix - description Probe set description provided by Affymetrix 
9. Summary - Functional summaries included in the Locus Report provided 
by NCBI 
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10. Gene ontology - Controlled vocabulary applied to the functions of genes 
and proteins. Functional classifications used here are those included in the 
Locus Report provided by NCBI 
Visualizations in DAVID are a combination of HTML pages and images 
generated on the server for each requrest. The biochemical pathway maps are pre-
generated images hosted at Kyoto Encyclopedia of Genes and Genomes (KEGG) [111, 
112]. There have been a number of advances in mapping these pathways centered around 
the KEGG database, including efforts to transform these maps into interactive SVG 
documents [113-115]. DAVID also incorporates many features of the GOMiner Gene 
Ontology mining tool [116]. 
MAPPFinder 
MAPPFinder [117] is another integrated visualization tool that will render images 
of differential gene expression in the context of gene networks, the Gene Ontology, or 
biochemical pathways. MAPPFinder uses the Gene Map Annotator and Pathway Profiler 
(GenMAPP) workbench to allow users to define their own diagrams or pathways for 
presentation.[118, 119]. In addition to displaying the gene expression in a variety of 
contexts, MAPPFinder will identify patterns of gene expression correlation in the Gene 
Ontology. The diagrams and analysis results of MAPPFinder sessions can be shared 
online using the MAPPFinder web site archive. The recent release of GenMAPP 2 
exposes many new visualization capabilities to the user. Pathways can now be translated 
between species using homology information. A new mode of data visualization supports 
analysis of complex data, including time-course, single nucleotide polymorphism (SNP), 
and splicing. GenMAPP version 2 also offers innovative ways to display and share data 
by incorporating HTML export of analyses for entire sets of pathways as organized web 
pages. 
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Problems of Data Scale 
One reason that so many visualization systems are designed as standalone tools or 
designed to connect only to pre-defined local databases is the scale of the data involved. 
The idea of plugging visualizations of such large-scale data as 30,000 genes on a 
microarray, 100,000 proteins in an interaction network, or billions of base pairs on a 
genome into a grid-based workflow for multiple-sample comparison has been technically 
infeasible up to this point. One obstacle has been that interoperability standards such as 
MAGE-ML [92, 120] or BioPAX [94], while extremely useful for passing meta-data 
about experiments around, cannot be extended to raw experimental results because the 
uncompressed text and required tags are too bulky. A balance must be found between 
appropriate meta-data to transport in structured formats versus bulk data to transport in 
standard compressed formats. A recent move in this direction is MAGE-TAB [121], 
which emphasized the facility of moving data between human-readable spreadsheets and 
machine-readable data files as a major usability factor for microarray analysis tools. 
Achieving Usability with Scalable Vector Graphics (SVG) 
A little over a decade ago, there was a lot of excitement around applets when Java 
technology was first released. This architecture built around the small, highly interactive 
applications available through your web browser spawned many spin-offs, including 
Macromedia Flash Applications and Microsoft ActiveX Controls. Of these three, Java 
applets were the only applications that could be developed without buying proprietary 
development software. Unfortunately, they suffered from stability problems, highly 
restrictive security limitations, and could not be easily scaled beyond single-purpose 
modules. For most of the past few years, users were forced to content themselves with the 
simple “click – hourglass – complete page refresh” interactivity of HTML forms when 
using web-based systems.  
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In 2003 the Scalable Vector Graphics (SVG) specification was approved by the 
W3C and received native browser support. SVG documents describe 2D graphics in an 
efficient way and can preserve the underlying scientific data. SVG documents can be 
annotated with custom tags to provide extensibility and tighter application integration. 
All SVG documents are zoomable (multi-scale) interfaces. This means that the resolution 
of the display device (or the available screen space in an integrated application) does not 
affect the readability of the scaled representation of the graphic. Finally, SVG documents 
can be programmatically manipulated using the Javascript Document Object Model 
(DOM), providing a means to implement innovative interactive interfaces. SVG has an 
important drawback in the lack of a standard set of widgets (buttons, sliders, select boxes) 
that make user interface creation much easier. SVG-based bioinformatics tools are not 
common. Some examples are GeneWindow [13], ArrayXPath [122], the microbial 
genome viewer [123], caCORRECT [18] and GOMiner [116]. SVG could be the basis 
for multimodal scientific and educational material in the future [124].  
SVG rendering is provided in Microsoft Internet Explorer 7 by means of an 
unsupported Adobe SVG Plugin but is natively supported in the latest releases of the 
Mozilla Firefox, Apple Safari, Google Chrome and Opera browsers. SVG is compatible 
with Asynchronous JavaScript and XML (AJAX) technology. AJAX is a technique for 
manipulating an HTML-based user interface using background browser processes 
without causing the noticeable page refresh of classic HTML forms. AJAX has the 
advantage of being similar in look and feel to locally installed software. However, AJAX 
without SVG must rely on reloading of server-generated images to improve the 
interactivity of visualizations. Web-based visualization technologies have many trade-
offs between openness, performance, and capabilities (see Table 4). The choice of SVG 
as a standard for SimpleVisGrid was made because of unparalleled openness, flexibility 
for data storage, scripting, and availability on mobile platforms like the iPhone. 
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Table 4: Comparison of visualization technologies for the web. 
 






Interactive or animated 
web content with wide 
range of complexity 
1996 Adobe Director (~$300) 
GUI container for Java 







Open-source and plain 











with building web 
workflows and mashups 
2007 
Free on the 





Competitor to Adobe 
Flash, which was 
perceived as the 
dominant technology 
2007 Free Microsoft Silverlight 
Introduced by Apple 
Safari and has been 
slowly adopted by other 
browsers 
2008 Free, No IDEs identified 
HTML5 Canvas 
Element + AJAX 
BioPNG: Data Compression & Visualization 
Portable Network Graphics (PNG) is an open specification for image 
compression. Since images are simply representations of 2D data matrices, it is somewhat 
intuitive to think of image formats as candidates for storing data in this form. However, 
we found no examples of systems making use of image compression to store non-image 
data. There are two reasons for this: (1) general compression formats such as ZIP have 
been the obvious choice for compressing any data and (2) image formats tend to have 
limited bit depth and/or lossy compression algorithms that meant the data you got out 
might not match the data you put in.  
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We introduced BioPNG, a method for converting floating point numbers into 
color channels for storage in a lossless format, as a companion technology to ArrayWiki 
[68]. This format has many advantages over ZIP: (1) it is natively supported over HTTP, 
(2) it is presented easily in browsers so the data can be “seen” as it’s received, (3) the 
compression rate compares favorably to ZIP, often performing 20-30% better, (4) PNG 
files do not harbor viruses like ZIPs can, and (5) meta-data such as scale (x and y 
dimensions) are easily extracted without parsing. Figure 19 illustrates the trade-offs of 
different BioPNG formats. PHP Source code for BioPNG can be found on ArrayWiki: 
http://arraywiki.bme.gatech.edu/index.php/BioPNG_Source_Code. 
The BioPNG algorithm was developed to allow ArrayWiki to scale up faster 
while requiring fewer storage and network resources. Compression of laser scanner 
microarray data has been addressed by Luo and Lonardi [125]. The authors stress the 
importance of lossless compression and compare compression results of JPEG-LS, JPEG 
2000, PNG, and TIFF image formats. They recommend JPEG 2000 but concede that this 
format lacks common browser support on the web. They also suggest (but don’t 
implement) separating header info, foreground, and background pixels. As a trade-off 
between good compression, portability, and ready viewing of data, we have found PNG 
compression to be the most convenient. 
Compression of Array Data 
BioPNG works by first splitting the numerical formats into coarse-grained and 
fine-grained bins (see Figure 19), and then making use of higher-order filters available in 
the PNG library to model the data and store only the errors in the model. Affymetrix 
microarray data contains many non-Gaussian correlations in the data that can be 
exploited for the purposes of compression. Our research has shown that different 
microarray platforms can differ significantly in the entropy (in the information theoretical 
sense of the term) of the data. We have calculated the first-order entropy of the 
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HG_U95Av2 platform, containing 409600 intensity values, to be 10.1613 bits based on 
the samples we’ve processed. This means that an optimal first order compression 
algorithm should create files of average size 520.25 kilobytes (kB). By comparison, 
BioPNG compresses this data into files of size 767.42 kB. Including more chips in the 
calculation of entropy will certainly raise this estimate, as not all of the available intensity 
symbols were used in our study. Our results indicate that BioPNG compression performs 
better than any custom first order compression algorithm, while still providing good 
portability and visualization. 
Most repositories provide gene expression and probe intensity data in a zipped 
format. This can be problematic when attached to emails and may be infected with 
malicious software by anonymous sources when shared on the web. BioPNG encodes 
Affymetrix probe data at 2.26 times compression over GEO’s method of zipping each 
binary Affy file individually and then zipping all of the files again into one file. 
BioPNG’s level of compression comes at small performance expense and no loss of data 
from the most important probe intensity measurement. Data stored in the file header are 
automatically transferred into the experiment metadata in ArrayWiki. 
Individual probe data is impossible to measure with current scanning 
technologies, but this is likely to change with technological advances. As the space 
savings indicated in Table 5 become greater, the coding effort and computational expense 
to extract specific data points out of the files become greater. Retrieving a small set of 
intensity values from BioPNG is much faster because only those selected pixel values 
need to be converted. 
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Table 5: Microarray data storage formats and relative compression ratios. 




(pixels) Size (KB) 
Size as PNG 
(KB) Space Savings 
TIFF 1926x1974 7428 729 90.2% 
GIF 1877x5486 9358 7975 14.8% 
DAT 2920x2920 16654 10786 35.2% 
DAT 8661x8661 146533 89497 38.9% 
Probe Intensity Data (Avg of 4 712x712 CEL Files) 
FileSize (KB) Binary Double gzip’ed BioPNG Data Format 
ASCII Text 11,683 57.6% 81.8% 91.9% 
Binary (Affy v4) 4953 - 57.0% 81.0% 
Double gzip’ed 2130  - 55.8% 
BioPNG 942   - 
Gene Expression (Avg of 4 CHP files, 22812 probe sets) 
Data Format FileSize (KB) Excel native Zipped CSV BioPNG 
Excel native 2718 - 70.6% 91.6% 
Zipped CSV 799  - 71.5% 





Figure 19: Illustration of BioPNG encoding. BioPNG specifies encoding methods for 
many types of numerical formats into the color channels of a PNG file. A. The trade-offs 
to be considered between precision, data range, visual appeal, and compression when 
selecting an encoding scheme. Encoding a value simply requires converting to a binary 
decimal and splitting the resulting string into bit lengths to fit into the color depth 
required to store the data. The images along the bottom are all Gaussian surfaces stored at 
various decimal precision. PHP Source code for BioPNG compression and extraction can 
be found at the url: http://arraywiki.bme.gatech.edu/index.php/BioPNG_Source_Code  B. 
The seventh line shows the encoding scheme used to encode 16 bits for Gel Plots, 
producing a grayscale effect. The final line of question marks the custom line is to show 
that the BioPNG API supports arbitrary definitions of color encoding. 
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Visualization of data distributions, data errors, and quality problems 
The BioPNG data format provides features for ensuring data quality in addition to 
providing compression and protection from malicious software. The ArrayWiki import 
process generates a histogram of the original and the clean intensity data. This histogram 
stores the counts for all 490,000 possible values for intensity measurements in 
unprocessed CEL files, and the corresponding counts after the artifact removal process. 
Viewing this file can indicate data problems if single values are strongly over-represented 
or if an unexpected periodicity is observed in the data. Another histogram image stores 
the probability density function for each of these values, which is simply the hit counts 
normalized so they sum to 1. These images are useful in calculating the first- and second-
order entropy of different microarray platforms. 
The Gel Plot visualization is another application of the BioPNG format to the data 
quality problem (see the example in Figure 20). The Gel Plot is created by first 
converting the intensity values into the log10 space, and then binning the values into 600 
bins. Like other BioPNG formats, the decompression method can perfectly reconstruct 
the log10 intensity counts used to create the file.  
Quality problems may arise in the algorithm that converts the intensity values 
read by the scanner (available in the DAT file) into the values reported in the CEL file. 
The final effect on reported gene expression has not been quantified, but the extent of the 
potential problems is visualized by the BioPNG-formatted NPIXEL file. This column of 
data in a CEL file indicates how many pixels were used in the calculation of the intensity. 
This number generally ranges from 12 to 36. Systematic patterns in this image may 
indicate misalignment between the track of the laser and the grid of the microarray spots. 
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Figure 20: The BioPNG Gel Plot. (A) The gel plot of the original scanned data for the 
Renal Cell Carcinoma Affymetrix X3P GeneChip. The arrow indicates a chip with a 
corrupted file format, causing the intensity values to be read incorrectly. The 
Bioconductor program that parsed the chips did not catch this error, but it became clear 
after visualizing the intensity distributions. (B) The gel plot of the normalized and 
artifact-replaced data output by caCORRECT. These distributions are clearly well-
aligned, but the same data parsing problem persisted without causing any post-processing 
algorithms to generate errors. 
 
Extension of BioPNG to all 2D Data Types 
Partly inspired by Matrix2PNG [110], we extended BioPNG to support multiple 
data types and to allow the user to arbitrarily choose color channel assignments in order 
to help users differentiate between different data types (see Figure 21). An interactive 
web site was developed to allow users to experiment with different options, and to show 
in what cases data can be completely recovered and in what cases some data will be lost. 
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A.      B. 





Figure 21: Examples of BioPNG Compression output using synthetic data. A. and B. 
This data file is a linear gradient from 0 to 1. The data precision makes only two color 
channels necessary, so red is not used. In (A), the blue channel encodes the lower order 
bits and in (B), the green channel encodes the lower order bits. C. This data file is a 
Gaussian curve starting at 1 in the center and dropping to 0 at the corners. While many 
visual artifacts do arise due to discontinuous bit incrementing, the overall smooth circular 
trend can be observed. The precision of this data requires all three channels to be used for 
complete reconstruction of the data. Data displaying gradual trends such as these 
compress very well using the PNG algorithm. 
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SimpleVisGrid: Visualization Services for the caBIG Community 
With a wide variety of available visualizations, a necessary first step in the design 
of a real working system is to narrow the range to those especially suited for biological 
knowledge. Figure 22 shows one possible classification system. The main categories are 
Networks, Correlations, and Images. A large class of simple plot visualizations like 
scatter plots and histograms could be considered a fourth class, but I group those under 
correlations to simplify the system. Images were discussed in the previous section, with 
the exception of a technique using the Animated PNG (APNG) specification to encode 
data cubes into a series of PNG files that will animate using a browser like Mozilla 
Firefox. Though this technique is available in SimpleVisGrid and offers many similar 
advantages to BioPNG, the compression is less than ideal because each 2D file is 
compressed in the standard way and no additional filters are run in the third dimension. 
This section will highlight network and correlation visualizations. The network 
visualizations work as a wrapper around the GraphViz library of algorithms, and so 
support a great deal of flexibility with improved visual appeal using SVG. Only the most 
novel correlation visualizations are presented here: feature landscapes and meta-data 
correlations. Correlations may best be presented using either SVG or PNG, depending on 
the scale of the data that must be rendered. Most of the visualizations presented here use 
microarray data as a case study, but these services could just as easily be used to 
represent other high-dimensional data types, such as mass spectrometry experiments or 




Figure 22: Classification of visualization technologies provided by SimpleVisGrid. The 
rectangles indicate the class, circles represent visual representations, and diamonds 
represent concrete examples of the representations. SimpleVisGrid supports only a subset 
of all of the possible methods to visualize heterogeneous data. The available 
visualizations are divided into three categories: Networks, Correlations, and Images. Six 
visualization types will be exposed, built upon two primary technologies: Scalable Vector 
Graphics (SVG) and Portable Network Graphics (PNG). All of the visualizations are 2D 
or 2.5D. In the case of the Feature Landscape, a single perspective is available on a 3D 
landscape. In the case of Animated Portable Network Graphics (APNG), 3D microscopy 
images are stored as many 2D images layered into a lossless compressed video animation 
file. Native support for APNG was added to Mozilla Firefox in version 3.0. Microsoft 
Internet Explorer does not natively support SVG or APNG, which is an obstacle to full 
adoption of data-embedded visualizations. 
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Visualizing Biological Network Relationships with Graphs: GridGOMiner and 
SphingoVisGrid 
Graphs are a natural way to encode biological relationships. Three examples 
include the visualization and analysis of: (1) ontological relationships between gene 
function terms, (2) biochemical networks such as lipid synthesis, and (3) shared 
components of complex processes such as the Human Disease Network [126-128]. 
Additional examples include (4) genealogy and genetic pedigree of individuals [129] and 
even (5) the Tree of Life online phylogentic collection collaboration [130, 131]. 
Network layout problems frequently arise in biomedical visualization. While the 
problems can be very large, requiring a great deal of computational time to render, many 
are small enough to be rendered using simple algorithms. A good package for providing 
flexible and easy-to-learn algorithms is GraphViz [132]. Our network layout visualization 
service (see Figure 23 for an example) is a wrapper for GraphViz and provides higher-
quality SVG documents than those obtained directly from GraphViz, including buttons to 
navigate among time series data and support for encoding information in the edges. We 
support many of the standard features of the GraphViz package in addition to automatic 
generation of a PNG file and embedding the original source data into the SVG document 
that is returned. In addition to biochemical reactions, the network layout service supports 
the layout of directed acyclic graphs (DAGs) like the tree structure used to represent 
relationships between terms in the Gene Ontology. 
In developing a general framework for these visualizations, I studied eGOMiner 
for integrating multi-experiment GO functional analysis. Additionally, I adapted this 
analysis specifically for looking at drug response (time series) experiments in the context 
of a Human Disease Network [128] in a system called nanoDRIVE. I also deployed a 
visualization system with accompanying database, PathwayVis, which integrates data 
from PubChem, LipidMAPS, and quantitative mass spectroscopy experiments to display 
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molecular concentration measurements on complex biochemical pathways. This system 
supports comparisons between empirical data and simulation results.  
These efforts have not been published, but improved my understanding of the 
diversity of data involved in building flexible grid services. The three tools have very 
different inputs, outputs, and interpretation goals, but they have very similar system 
components.  
eGOMiner: Comparing Gene Functional Significance Studies 
The GOMiner [116] tool has been used widely to interpret the results of 
microarray experiments [133-135] (the paper shows 375 citations in the ISI Web of 
Science database from Thompson). This tool takes a list of predetermined “significant” 
genes as an input. This list may come from one of many methods to identify significant 
genes (e.g. hierarchical clustering, Significance Analysis of Microarrays (SAM) [136, 
137], Gene Set Enrichment Analysis (GSEA) [138, 139], fold change or p-value filtering, 
or machine learning and classification methods). GOMiner counts the appearance of 
these genes in association with ontological terms and uses the Fisher’s Exact statistical 
test [140] to estimate a p-value to indicate if “significant” genes are over-represented in a 
functional category.  
In preliminary work targeted at enhancing these types of studies, we have 
implemented a system that can compare these p-value results among lists of significant 
genes generated by numerous methods, or generated by heterogeneous data sets. The 
original GOMiner tool was a standalone Java application that could connect to a local or 
remote database, but required installation on the user’s desktop PC. It also involved a 
“Windows Explorer”-style hierarchical interface for most use cases. eGOMiner [141] 
was a web-based system that made use of SVG visualization and interactive navigation to 
enhance the user experience. The eGOMiner system contained many graph layout 
problems, including unnecessarily crossed lines, limited ability for functional results 
comparison, no consideration of the potential for graphs to overwhelm the system as the 
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Gene Ontology database grew over time, and limited interoperability with other systems 
in the research workflow. The key improvements in my work on eGOMiner are 
integration of a much simpler and more effective graph layout system, pre-filtering of 
terms based on p-value to manage the overall tree size, and definition of a caGrid UML 
model so that GOMiner functional results can be integrated into other grid-based 
systems. 
 
Figure 23: eGOMiner graph visualization of ‘biological process’ ontology branch of the 
Gene Ontology. Each node in the Gene Ontology is a biological term (classification of 
gene function). The nodes nest inside each other as the terms progress from general to 
specific functional classifications. This visualization uses a combination of GraphViz for 
generating an appropriate layout and custom code for generating the colored nodes for 
comparative information. The yellow, aqua, and green sections of each node represent 
three separate input gene lists under analysis. The opacity of each rectangle represents the 




SphingoVisGrid and PathwayVis: Comparing Quantitative Lipid Synthesis Pathway 
Experiments 
The field of metabolic pathways is full of useful examples of how interactions 
between branching pathways can cause dramatic growth in complexity of analysis and 
visualization [142]. Certain areas of the biological domains can be simplified so that the 
representations follow a hierarchy, with limited interconnections among low-level 
branches. For these domains, two-dimensional graphs can be delivered through web-
based tools for interactive exploration on a variety of devices. 
One example well-suited to this type of simplification is the Glycosphingolipid 
synthesis network [143]. Sphingolipids are a component of cell membranes of many 
species and their intermediates and products regulate diverse cell functions. The 
metabolic pathway of sphingolipids has thousands of individual components, which are 
investigated using separation columns and tandem mass spectrometry [144, 145]. These 
instruments produce high-volume datasets that are challenging to interpret.  
Sphingolipids are comprised of a sphingoid base backbone and a variable-length 
fatty acid chain. The sphingoid base is synthesized de novo from serine and an acyl-
coenzyme-A and may be converted into ceramides, phosphosphingolipids, 
glycosphingolipids and other species (for example, phosphocholine for sphingomyelin, 
and sugars for glycosphingolipids). There is considerable variation in all of the 
components, including several hundred known variations in glycosphingolipid 
headgroups, over 70 sphingoid base backbone varieties and dozens of amide-linked fatty 









Theorized based on 
chemical properties Modifiers 
Head Group 8 150+ 400+  
Backbone Chain 




2 3 3 
Fatty Acids 2 3 3 
Total Combinations 384 12,150 72,000 
 
 
PathwayVis is a web-based and database-driven visualization tool that stores 
experimental and simulation results and can compare the concentration changes in the 
context of the pathway (see Figure 24). This system has been used to support studies of 
the GlycoSphingolipid biosynthesis pathway [146]. This pathway has been partially 
loaded into the LipidMAPS database [147], and the PubChem database of chemicals 
[148]. Scalability of this visualization is an extremely important feature of this software, 
because of the combinatorial nature of the structural components of the chemical species.  
Quite a few popular pathway visualization tools have been developed, including 
CellDesigner [149], CytoScape [106], COPASI [150], and JSim [151]. One system that is 
tailored for a specific community is GlycoVis [152]. Most of the many tools available are 
only available for running locally and do not support web-based visualization or grid-
enabled APIs. Computer scientists have extended the basic graph visualization work 
offered by GraphViz using techniques such as 2.5D pathway maps [153] and 
Focus+Context hierarchical navigation [154].  
PathwayVis and SphingoVisGrid are differentiable from previous work in the 
technical implementation decisions and in the design objectives. The technical decisions 
enable web-based access and exploration, including through popular mobile devices (see 
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Figure 26). The design objectives make this system customized specifically for the 
lipidomics community instead of trying to solve a general problem. Systems that treat all 
problems as the same tend to compromise the usability and extend the learning curve of 
the system for non-computational biologists. Technical decisions were made to enhance 
the usability of SphingoVisGrid, leading to the use web-enabled PHP and SVG 
programming technologies and support for uploading Excel spreadsheet data already in 
use by experimental scientists using the comma separated values (CSV) format (see 
Figure 25).  The user interface supports navigation of time series data and will create a 
pie chart graphic to support comparisons between similar chemical species in the 
pathway.
 
Figure 24: PathwayVis screen shot. This SVG rendering of a partial sphingolipid 
biosynthesis pathway displays the k-values predicted by a parameter estimation algorithm 
on the edges and the difference between the simulation predictions and the empirical 




Figure 25: Annotated SphingoVisGrid screen shot. This SVG rendering contains two 
views of the same data measurements. In the first view (top), the data is formatted 
similarly to the data input file. Both the data input file and the grid visualization were 
organized conceptually by the biological domain scientists. The second view (bottom) 
displays the data in a branching radial view that is more indicative of the biochemical 
pathway. Both views have been annotated by a domain scientist (Dr. Al Merrill) to reflect 
details of the molecules under study. The system is flexible enough to support branching 







Figure 26: SphingoVisGrid on the iPhone mobile device from Apple. One of the primary 
motivations for using SVG in the SimpleVisGrid visualizations is that it is becoming 
widely supported for mobile devices. The graphics are represented mathematically, so 
panning and zooming are simple to implement and always produce crisp images, which is 
crucial for small screen space devices. A) The nodal view. B) The same experiment in the 
grid view, zoomed in (~4x) on a complex part of the pathway using the touch controls. 
The iPhone platform currently does not support Adobe Flash applications because of 




Visualizing Correlations: Feature Landscapes and Correlation Heatmaps 
Another important aspect of comparing widely varying and multi-scale biological 
data is the ability to detect similarity and differences among massively high-dimensional 
datasets. Feature landscapes are an example of using the SVG format to depict 2.5D 
visualizations. Although the peaks and the background appear to have depth, they are 
positioned on the graphic using pre-built symbols. Each peak symbol contains custom 
attributes providing an ID for the feature and the exact number of times it appears in the 
provided data, as this information could never be recovered from the X,Y location of the 
peak in the graphics file. I have used feature landscapes in my research to see if tuning 
certain parameters in feature selection algorithms significantly affects the results. I am 
developing an algorithm for summarizing the similarity between the feature lists for a 
future publication (see chapter 5). 
For microarray studies, it may be useful to compare the analysis results of many 
different teams to determine how much agreement there was among the teams on the 
most important features of the data. This was an important contribution to the FDA 
MAQC Phase II project because over 30 teams attempted to analyze the same 13 
endpoints of the six provided datasets. Gene landscapes are a rich source of information 
because they combine a sense of the scale of the problem (the amount of gray space and 
the narrowness of the feature peaks) with a measure of frequency of selection of certain 
features in the large solution space.  
Many studies (e.g. Genome-Wide Association Studies (GWAS)), attempt to 
correlate disease states with genomic variations using datasets of large sample size 
(thousands of genotype study results). These correlations are not necessarily the endpoint 
of the study, but must be collected in a large database for searching and querying 
operations in order to test hypotheses. For this reason, results of these correlations are 
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stored in a BioPNG format and provide query operations to quickly retrieve the images 
into memory and retrieve a row, column, or single pixel from the image.  
High-dimensional, high-throughput data acquisition methods have a tendency to 
suffer from a phenomenon called “batch effect.” This is an overall bias applied to the data 
based on the period of time that the data was acquired. Batch effects may be caused by 
environmental factors, human error, changes in equipment or changes in lab protocols. It 
is very important that these problems are corrected before data analysis models are built, 
because the bias can become the dominant feature of the data. 
Our meta-data correlation visualization can be used to detect batch effect, but can 
also be used to evaluate experimental design problems, such as sudden changes in chip 
quality, inappropriate randomization procedures, and relationships between clinical 
factors that might be useful to exploit when building a data analysis model. These uses 
are discussed fur-ther in chapter 5. 
caBIG Certification Preparation of SimpleVisGrid 
The reason SimpleVisGrid is simple is because only two input formats are 
accepted and only two output formats are provided (see Figure 27). SimpleVisGrid 
services are based on a UML Model constructed in Enterprise Architect (see Figure 28). 
Common Data Elements (CDEs) have been identified and semantically annotated using 
the Semantic Integration Workbench (SIW) provided by caBIG. Where necessary, new 
concepts have been identified and defined for insertion into the Enterprise Vocabulary 
Services (EVS) ontology for cancer research. These practices mean that we can build a 
submission package for Silver-level certification of SimpleVisGrid. 
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Figure 27: Schematic of the grid services making up SimpleVisGrid 1.0. 
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Figure 28: Semantically annotated SimpleVisGrid UML Model describing the input and 




FDA MAQC PHASE II CASE STUDY 
Participation in the United States Food and Drug Administration (FDA) 
Microarray Quality Control (MAQC) Project provided an opportunity for me to apply the 
expertise I acquired in developing caCORRECT and ArrayWiki to investigate the impact 
of additional microarray experimental quality factors on clinically-relevant problems. My 
work was included in three papers submitted for publication in the MAQC special issue 
of Nature Biotechnology. This work is currently under review, so in this chapter I provide 
a brief overview of my contributions. 
Background on MAQC 
Microarray gene expression data have been submitted by pharmaceutical 
companies to the FDA for a number of years to support claims about the safety and 
efficacy of Investigational New Drugs (INDs) and New Drug Applications (NDAs). It is 
important that the FDA conduct independent studies about the microarray technology 
before accepting this evidence in the place of more traditional approaches. Since the FDA 
is the gatekeeper for technologies that are in use in real medical practice, the impact of 
this work on translational biomedical informatics is large.  
The reliability of microarrays as a reproducible measurement technology has been 
brought into question by a number of researchers [156-162]. The MAQC Phase I Project 
demonstrated the technical reliability of microarray technology in detecting differential 
gene expression and was published in 2006 [42, 163, 164]. The FDA MAQC II Project 
answers questions regarding the reliability of the data analysis around the technology for 
clinical applications. Many different approaches to solving the problem of building 
predictive models were encouraged in order to explore the territory and ensure that the 
guidelines developed cover the range protocols in common use today. 
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Among the approaches developed by the 36 teams, the steering committee found 
the K-nearest neighbor (KNN) method proved to be one of the simplest and most robust 
classifiers. Despite this, large variations in prediction performance still occurred among 
the KNN models. The Georgia Tech team volunteered as an unbiased outside observer to 
investigate why this variation occurred. We designed a significant systematic study inside 
the MAQC project that would serve as a mini-MAQC. I contributed to the FDA MAQC 
Phase II effort in three ways: (1) I collaborated with John Phan in the development of 
models to be submitted for the Georgia Tech team, (2) I developed testing harness 
software to fully exercise the K Nearest Neighbors (KNN) classifier across a wide variety 
of parameters, and (3) I developed visualizations to help understand the meta-data 
Development of Models for MAQC-II 
caCORRECT was featured in the construction of models from Georgia Tech for 
testing the predictive power of gene expression results on three Affymetrix microarray 
platforms. Other methods employed included a genetic algorithm for selecting small 
combinations of genes and mining of the Gene Ontology for genes that were functionally 
related to the clinical scenario. Public results of this effort will be published on 
ArrayWiki along with accompanying source experimental data once the consortium has 
published its results and the data is no longer confidential. 
Investigation of Differential Performance of KNN 
The KNN classifier uses simple distance metrics between all points in a set of 
training data to build a set of size K neighbors. The neighbors then vote to choose the 
class of a new testing point based on their own class labels. Despite the simplicity of the 
KNN method, results from the MAQC-II Project suggest that there are factors within the 
population of KNN models that cause large variations among prediction performances by 
different teams. Given the fact that KNN is a common method used in data analysis 
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studies, it is an ideal proof-of-concept classifier for us to gain insight about 
reproducibility and reliability in microarray-based predictive model development. 
We designed a combinatorial study of 463,320 KNN models by varying nine 
parameters for each of the ten endpoints from three clinical datasets: breast cancer [165], 
multiple myeloma [166], and neuroblastoma [167]. The parameters varied were (see 
Figure 29): 
 K (number of neighbors) on a range from 1 to 30. 
 The metric used to calculate distance (euclidean distance, cosine distance, or 
city-block distance)  
 The method of feature selection (SAM, P-value, or fold change) 
 The number of features selected (5:5:200) 
 The method used to calculate voting among the neighbors (equal-weight, 
prevalence-weight, and distance-weight) 
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Figure 29: Workflow of the KNN investigation. Our system design is similar to the 
reductionist approach employed by biologists to extract components of the system that 
are related to each other by fundamental properties. The metaphor of the column on the 
left is that of a liquid (or affinity) chromatography column. Four datasets were passed 
through the same combinatorial approach, where a parameter was cycled through 3-30 
possible values to create a comprehensive results dataset. That dataset was mined using 
ANOVA to determine the relative contribution of each parameter type to the performance 
variation. Each parameter was also classified according to its impact on reproducibility of 
results on the same data (measured during cross-validation) and on external data 
(measured using the blind validation dataset provided by the FDA).  
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Identification of Modeling Factors Affecting Performance.  
Analysis of Variation (ANOVA) was used after separating models by each factor 
studied to determine the relative effects of modeling factors on performance. Each 
modeling factor is selected in turn and a one-versus-rest comparison is used to measure 
variance. The results of a preliminary ANOVA are shown in Table 7. These results show 
that the impact of KNN-specific parameters is dwarfed by the impact of innate data 
properties. Thus, it seems that in looking to improve performance of KNN models, 
addressing problems in the data can contribute the most to improvement. 
 
Table 7: Sources of variation (ANOVA) in external validation performance 
across six FDA clinical scenarios. 
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 Analysis of Dataset Properties.  
I employed a new quality control technique in the process of investigating why 
one participant in the MAQC project reported significantly better results than others 
using similar methodologies. We hypothesized that the source of this performance 
advantage was a method of dropping samples from their analysis that might contain 
confounding data. We compared a chip-to-chip correlation plot with various technical 
features of the data for four datasets to verify this hypothesis (see Error! Reference source 
not found. and Figure 30). The resulting visualization was found to be even more useful 




Figure 30: Chip-to-Chip correlation plot for FDA MAQC-II multiple myeloma dataset. 
The colored bars along the bottom allow someone to draw a variety of conclusions. First, 
you can compare the selection of a training set to the validation set. The method of 
sample collection and assignment to training/validation is non-random (as observed by 
the red diamond where Scan Date meets the training/validation labels. This will make a 
dataset more prone to batch effect bias. This is the largest dataset available from MAQC 
and exhibits no batch effect like that found in other datasets. A few chips have very poor 
scan quality, but they do not appear to have a high misclassification rate. The two 
samples indicated by red arrows might indicate borderline or incorrect clinical labels. The 
F clinical endpoint label is a complete subset of the G clinical endpoint label. This 
indicates that a joint classifier would work better than two independent classifiers. 
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Visualizations for Understanding MAQC Meta-data 
In addition to working on a project specific to our Georgia Tech team, I 
contributed some visualization expertise to support the claims of the MAQC main paper 
led by Dr. Leming Shi. My primary role in this effort was to compare the lists of features 
selected by all 36 teams to determine how much agreement there was among the teams. 
The agreement was found to vary considerably depending on the difficulty of the clinical 
scenario and the quality of the data. I used feature landscapes to visualize the amount of 
agreement, both on the original training data and in comparison to the building of models 
on the blind validation data during the “swap” analysis. I developed two metrics to allow 
for summarizing the agreement among feature lists into a single number. One metric 
works best for unranked lists of the type submitted by the teams for their models. In this 
case I used the Fisher’s exact statistical test to generate a p-value of the likelihood that 
the two lists were generated by random chance. The second metric is based on a novel 
algorithm that takes into account the ranking of two lists, and was used to compare the 
lists produced by the three ranking methods for the KNN study. Both metrics work well 
when the lists have different numbers of elements, unlike many existing methods such as 
Borges Count or Canberra Score. 
Feature Landscapes 
The feature landscape is a 2D histogram where estimates of molecular 
concentration or any other biological feature that might make a useful biomarker are 
arrayed using any sort order. The histogram is presented in 2.5D to give a more dramatic 
presentation, and to guide the eye at quickly recognizing pairs of peaks when comparing 
two landscapes. Peak heights provide for quicker recognition than using color only. 
Figure 31 shows landscapes generated for the KNN study of three simple feature ranking 
methods: Significance Analysis of Microarrays (SAM), fold change ranking after P-value 




Figure 31: Feature landscapes comparing features lists generated by KNN study. Nine 
feature ranking methods were compared while testing the KNN “full monty” systematic 
study. The three fundamental types were SAM, fold change, and p-value. For fold change 
and p-value, there were a few minor parameters that created four unique methods for 
each fundamental type. The landscapes with the hot colormap show agreement between 
the nine methods using training data and the cold colormap shows agreement on 
validation data. The merged colormap (green and purple) shows agreement among 
feature selection methods between training and validation datasets. Agreement is higher 
for training in general because it has a larger sample size. Agreement for I and M is small 
because the class labels were randomly assigned as a negative control. The design of the 
microarray platform for endpoints FGHI is the most likely reason for the bias toward 
features in the middle band of the gene list. 
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Development of Distance Metrics for Feature Lists 
The feature landscape visualization gives an impression of overall agreement of 
feature ranking methods and can confirm expectations about difficulty or point to 
experiment design problems. However, it is also useful to generate a single number that 
measures the similarity between two lists. In working on the MAQC-II project, I 
developed a list of two shortcomings of microarray classification studies that were not 
addressed in the literature, and which could be improved: 
1. Reporting of “unranked” gene lists. Ranked gene lists necessary for solid 
comparisons between competing gene lists and effective merging of lists from different 
studies. Unranked gene lists are selected using an arbitrary cut-off based on various 
performance metrics. Even when the cut-off is reported, it does not aid in further 
trimming the gene list or prioritizing the gene list for external validation. The best 
ranking beyond a discrete numbered list is a true confidence score reported by the 
ranking algorithm. 
2. Lack of a metric for comparing similarity between two feature ranking 
results. This metric might be useful for comparing to “knowledge” such as previously 
validated biomarkers or knowledge gleaned from literature or stored in a database such as 
the Gene Ontology (GO). Existing methods, such as Fisher’s Exact, assume unranked 
lists, but a more precise measure can be obtained when using ranked lists. 
I addressed these issues by adapting the existing Fisher’s Exact statistical test as a 
distance metric for unranked feature lists and by developing a new distance metric for 
ranked feature lists. These methods can be extended to problems beyond biomarker 
identification using microarrays. There are many examples of problems in biology where 
ranked and unranked asymmetric sets are compared and many of these scenarios could 
make use of a distance metric for quantifiable comparisons.  
 100
Normalized List Similarity Distance for Ranked Lists 
R(x,X) is the rank operator, which returns the integer rank > 1 of the x element of 
the ranked list X, or the confidence value > 1 of that element. L(X) is the length of the 

































































































The normalized List Similarity Distance is simply the calculated value divided by 











A calculation must meet the following criteria for all x, y, z in X to be considered 
a distance metric: 
1. d(x, y) ≥ 0, (a.k.a. non-negativity)  
2. d(x, y) = 0 if and only if x = y, (a.k.a. identity of indiscernibles) 
3. d(x, y) = d(y, x), (a.k.a. symmetry)  
4. d(x, z) ≤ d(x, y) + d(y, z), (a.k.a. triangle inequality). 
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Of these, the first three can be generally satisfied by inspection. The fourth 
requirement is more difficult to prove. It was ultimately proven for lists up to six 
members in size by exhaustive search (see Figure 32). 
Study of Feature Selection Stability Among Common Ranking Methods 
In the objectives of the MAQC-II project, reproducibility of features among 
differing data analysis protocols (DAPs) was not emphasized as the most important 
quality measure. However, for clinical applications of microarray classifiers, including 
selection of candidate patients for personalized treatment with new therapies, a fixed and 
validated set of biomarkers must be arrived at in some way. So, as a way of looking at the 
end goal of many readers of the MAQC-II results, we consider the reproducibility of 
feature lists of proven biological significance (i.e. that will hold up to validation using 
methods more sensitive than microarrays). 
Accurate measurement of these two qualities of a classifier is an open question. 
Our metric emphasizes the rank order of each feature list, the size of intersection between 
two lists, and the difference between the two lists.  Figure 33 shows the results for 10 
endpoints varying the number of features from 25 to 125 in steps of 5.  A distance of zero 
(light blue) indicates perfect matches between gene lists.  A distance of 1 (dark blue) 
indicates complete disagreement between lists.  Of the three feature selection methods we 
evaluated, we found that ranking by fold change with a p-value threshold of 0.05 (FC+P) 
provided more robust gene lists in terms of genes being likely to appear in similar ranks 
on lists generated across the 50 cross-validation gene lists.  This is particularly apparent 
for the mid-range difficulty endpoints: D, F, G, J, and K.
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Figure 32: Histograms of complete scoring results of all possible permutations of lists of 
varying sizes. This series of histograms showing the distribution of values for the list 
similarity distance metric with lists of varying sizes and a total pool of features of 15. The 
data in the histogram are the results of scoring every possible permutation of lists from 
the 15 features exactly once. The penalty associated with mismatches is the reason for the 
separation between the segments of the histogram. This penalty varies based on relative 
lengths of the two lists. The overall trend is for very few of the possible permutations to 




Figure 33: Feature set concordance among cross validation sets for each feature selection 
method and endpoint. Black indicates a large average distance, or difference, among 
feature sets from different cross validation folds or iterations. White indicates a smaller 
distance, or more similar feature sets. Within each endpoint, feature size increases from 
top to bottom. As feature size increases, concordance of lists tends to decrease. The three 
ranking methods compared here are Significance Analysis of Microarrays (SAM), fold 






CANCER BIOMEDICAL INFORMATICS GRID (caBIG) 
CERTIFICATION 
The variety of biomedical data and tools has exploded in recent times. However, 
many such research tools will never be used by the larger user community because they 
were not interoperable with variety of platforms. The cancer Biomedical Informatics Grid 
(caBIG) has created a collaborative grid network addressing this issue through a semantic 
model-driven framework. In this chapter, I describe the path taken to re-design the 
microarray data quality control package, caCORRECT, to make it available to a wider 
clinical community through caBIG Silver-level compatibility review. Key software 
elements and functionality were identified and annotated following grid standards. 
Clinicians trained to use these tools may be confident that a strong community of 
developers is committed to delivering interoperable tools of the highest quality. 
Translational Biomedical Informatics (TBMI) will allow for much greater 
efficiency in sharing patient medical records and accumulating de-identified research data 
where allowed for by federal regulations. There are still many social as well as technical 
hurdles to overcome on this goal, but scientists and national leaders alike agree that this is 
an important mission for resolving the many problems related to the rising expenses of 
health care research, translation, and delivery.  
The establishment of a central ontology for cancer research called Enterprise 
Vocabulary Services (EVS) led to the merging of many of the leading medical 
ontologies. The Cancer Data Standards Repository (caDSR) requires that all identifiers 
used by grid-enabled, caBIG-compatible software be mapped to their component 
concepts using codes found in EVS. This laborious process will go a long way in making 
the function of software systems in medicine more understandable to doctors. The 
deployment of simple services (and accompanying new terminology) to caBIG is part of 
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the third objective of this dissertation for this reason. This work has been submitted to the 
American Medical Informatics Association (AMIA) conference and is under review. 
Cancer Biomedical Informatics Grid (caBIG) 
The caBIG project was launched in July 2003 at the National Cancer Institute 
(NCI) with the goal of creating the “World Wide Web of Cancer Research” [168]. caBIG 
is part of a national initiative to improve the health care information technology 
infrastructure to streamline the path from clinical data collection about patients to 
computational mining of the data to identify molecular profiles for personalized treatment 
[72]. It has been described in Nature as a “gradual revolution in working practice. [169]” 
Even this characterization is hopeful, as day-to-day operational challenges in the clinic 
present unfamiliar territory for the spread of computational research. The caBIG 
organizational structure is divided into working groups, each focused on different aspects 
of the interoperability problem specific to cancer research. Two overarching work 
groups, “Architecture” and “Vocabularies and Common Data Elements,” have begun to 
produce some very detailed specifications that will be extremely useful for guiding the 
design of interoperable bioinformatics tools [170, 171].  
The primary benefit of caBIG is that it provides a common platform from which 
to launch more ambitious integrated solutions. Bioinformatics laboratories can now adopt 
the basic infrastructure, databases, and functionality provided by caBIG working groups 
to fill gaps in knowledge and tedious information management responsibilities. This 
allows researchers to focus on their areas of expertise while still offering a complete 
solution to clinical problems such as tissue bank and equipment inventory, clinical trials 
management, and vocabulary services. 
caBIG project's aim has always been to raise the interoperability of tools and data 
relevant to bioinformaticians, biological and bio-molecular researchers, 
nanotechnologists and clinicians working to fight cancer [71, 168]. The need for research 
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tool and data interoperability is increasingly recognized as part of the critical path for 
advancing medical research. Studies show that data sharing between biomedical re-
searchers is on the rise, with possible causes being perceived increased impact of the 
scientific work as measured by citation counts [2, 29]. Researchers can share raw 
experimental data [172, 173] as well as their developed tools and results [25, 174] by 
porting their own code or by adopting and populating existing caBIG tools and databases. 
Physicians can benefit from clinical management tools and data integrated into the 
network [175, 176].  
The benefits of involvement in the Grid extend to developers. The open source 
structure makes integrating with existing tools easier. The development framework also 
allows for some automatic code generation and the involved user community makes 
deployment of new algorithms much faster and more rewarding. Despite these 
advantages, very few independent groups have submitted tools for caBIG Silver-level 
review. In fact, we were told by our mentors that we are the first development team to 
reach this milestone without funding support from caBIG. 
Most cancer research data is still isolated into the local control of groups 
responsible for creating and storing it. Making the data publicly available requires a fair 
amount of labor both in interpretation and arrangement before it is useful among 
collaborating groups. This phenomenon has been called an Information Tower of Babel 
and many current health care problems can be traced back to this root cause [9]. One 
trend is to amass data from many sources and put them into a single system for storage, 
analysis, and distribution. This trend most often results in data stores that are stale and 
difficult to maintain [20, 21]. Development emphasizing interoperability between 
disparate groups allows myriad systems to connect in a manner similar to the World 
Wide Web, allowing the network to grow in a federated manner. Efforts from academic, 
industry, and government entities can integrate their software and data all the while 
maintaining local control over both. Data pertaining to tissue samples, genetics, 
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treatments, and clinical trials can be made interoperable in a participatory process 
utilizing a layered set of standardized vocabularies. Tools responsible for housing and 
facilitating access to as well as analyzing such data are also good components of a 
comprehensive biomedical grid. 
In addition to these shared tools and architectural guidance, caBIG is a test bed 
for development of standard tools that can be understood, verified, and used by clinicians 
around the world. In its application workspaces, caBIG provides oversight and 
communication channels between researchers at cancer centers around the United States 
to improve the level of trust in tissue banking, clinical trials, and molecular data mining 
tools. The caBIG steering committee also regularly organizes surveys to gather feedback 
from clinical users and provide direction for the entire effort. 
There is an important potential for added value in the form of automated 
knowledge discovery workflows [177]. Just as news readers on the Internet can now set 
up alerts and crawlers that collect information as it appears on certain web sites, 
researchers can build larger functional blocks of research data processing that can 
perform a data analysis protocol on new data as it appears on the Grid. This potential for 
greater automation of data analysis is one of the key drivers of adoption of the Grid 
architecture. Greater automation should reduce data analysis errors and address the 
problems of “stale data” as well as “stale algorithms” which result from the need for 
significant human intervention in the process of upgrading computational resources. 
The idea of a national bioinformatics grid has also been proposed in the UK [178] 
and in France [179]. In the United States, the Virtual Observatory [180] and the 
Cooperative Human Linkage Center [181] are examples of great successes of grid-based 
science. caBIG may be the largest and most ambitious grid project being undertaken to 
date given the combination of its domain of focus, variety of data relevant types, 
semantic interoperability goals, and participatory nature. Already, projects are being 
initiated by the National Institutes of Health (NIH) for a Cardio-vascular Research Grid 
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(CVRG), building on some of the infrastructure developed by caBIG and deploying it to 
another large research community. 
Semantic Annotation for Interoperability 
Much of existing computing data is only available on systems which have no 
account of the meaning of the data. Search engines have alleviated the problem by 
grouping available data with human-understandable terms, but machines are ill-equipped 
to handle even elementary inquiries across different data sources. The effort to 
semantically annotate information aims to allow meta-data to provide meaning which can 
be utilized directly by computer systems (see Figure 34). Key use cases motivating the 
semantic annotation methods for caGrid include the discovery of tools and data, large 
scale data analysis, and workflow construction. 
Existing caGrid projects, such as caGridPortal, provide for the advertisement and 
discovery of grid services themselves. Maintainer institutions and available service 
operations are described by all open services to a centralized index server. This 
information is then, for example, available on a portal webpage for discovery of open 
services by anyone. The caGridPortal provides a web-based general search solution for 
grid services and participating institutions based both by name, location, and kind. Search 
by institute, domain model, objects using certain concepts, and services using objects 
related to certain concepts are some possible parameters of search allowed by the portal's 
indexing methods. 
Large-scale data analysis is another critical use case motivating the semantic 
annotation of data. Integrating different data types from heterogeneous services requires 
the meaning of data to be interpreted; and so metadata representing meaning allows more 
automated processing of different data types.  
Research facilitation by means of a grid service can benefit from semantic 
annotation in the linking of research and activity data across multiple sources, 
 109
incorporating multiple tools, data objects, and data sources. Grid Services developed by 
independent groups must be made to agree on the meaning of the data being passed 
between them. In some cases, adapter services will have to be designed to transform data 
between simpler and more complex structures based on the requirements of the next Grid 
Service in the workflow. A well-annotated model will make this task simpler and reduce 






Figure 34: Screenshots of caCORRECT entries in the Cancer Data Standards Repository 
(caDSR). 14 classes were created in our model and have been officially registered and are 
now available for re-use by other bioinformatics application developers. 
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Model-Driven Development and caDSR 
Usage of the Unified Modeling Language (UML) to construct a software design at 
the beginning of software creation allows greater design flexibility and system visibility.  
The UML model for caCORRECT is shown in Figure 35. In the case of data providing 
services, the UML model may be used directly to generate Java code using the cancer 
Common Ontological Representation Environment (caCORE) Software Development Kit 
(SDK) [170, 182]. The semantic annotation of designed elements relates concepts with 
CDEs. A single term registered with the Enterprise Vocabulary Service (EVS) is made 
the primary concept of the CDE (see Table 8 for examples). Additional concepts are 
added for enhanced clarity and specificity of meaning. A caDSR tool named the Semantic 
Integration Workbench (SIW) is the most prominent tool to aid in the procedure of 
annotating a model. 
The Enterprise Vocabulary Services (EVS) define a controlled vocabulary, or 
ontology, for terms specific to the cancer realm [183]. Existing ontologies (e.g. Gene 
Ontology and Unified Medical Language System (UMLS)) are referenced instead of 
duplicating work. EVS is regularly updated by merging updates to all the associated 
ontologies. The Cancer Data Standards Repository (caDSR) is the central registry for 
Common Data Elements (CDEs).  
The Cancer Bioinformatics Infrastructure Objects (caBIO) represent the 
biomedical domain as a hierarchical object model. These classes are freely available and 
can save bioinformaticians the trouble of implementing Simple Object Access Protocol 
(SOAP) and XML application programming interfaces for services that transact with 
CDEs. An even more exciting benefit of incorporating these classes into web services for 
new and legacy tools is that the end user application has a layer of protection from 
updates to data standards.  
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Figure 35: UML Diagram of the caCORRECT analytical grid services. This diagram is a 
complete description of all input and output data elements for the four caCORRECT grid 
services: MicroarrayQualityScore, MicroarrayVariationHeatmap, 
MicroarrayArtifactDetection, and MicroarrayGeneCalculations. All data types have been 
mapped to standards and all variable and class names have been annotated using a 
standardized vocabulary. This model reuses 6 data elements from the previously 
approved caARRAY model and 3 data elements from the Bioconductor model. Four new 
vocabulary terms were defined in making the model and a new architectural concept, the 
EndpointReference object was defined. The code and documentation generated for these 




Table 8: Concepts re-used or newly defined for the caCORRECT Grid Services. 
Term Definition 
A structure or appearance that is not naturally present, but has 
been introduced though manipulation. Artifact 
A binary number in which a bit is set to either on or off to 
store information for bitwise operations. Bitmask 
The appearance of objects (or light sources) described in terms of 
a person's perception of their hue and lightness (or brightness) 
and saturation. Color 
The act of directing or determining; regulation or maintenance of 
a function or action; a relation of constraint of one entity (thing 
or person or group) by another. Control 
Cover Span a region or interval of distance, space or time. 
Detection The activity of perceiving, discerning, discovering or identifying 
A graphical representation of data where the values taken by a 
variable in a two-dimensional map are represented as colors. Heatmap 
The state of being complete or undivided, of being sound or 
undamaged. Integrity 
The creation of a two-dimensional graphic representation of an 
area or structure, showing the relative position of features or 
characteristics. Mapping 
A piece of glass or plastic on which different samples have been 
affixed at separate locations in an ordered manner thus forming a 
microscopic array. The samples are usually DNA fragments but 
may also be antibodies, other proteins, or tissues. Microarray 
Raw Not processed or refined. 
A number or range of numeric values measuring performance, 




Community-Reviewed Grid Services for caCORRECT 
We have performed numerous studies on the progress of caBIG as an 
infrastructure project, as well as the progress of various components toward adoption in 
the caBIG community. One significant effort was the adoption of the tool caNanoLab to 
begin our involvement. Next we developed a preliminary set of grid services that expose 
the key elements of the caCORRECT workflow to any developer familiar with the caGrid 
infrastructure. Four grid service interfaces were developed to correspond to the key 
functional offerings of caCORRECT: 1) MicroarrayQualityScore, 2) 
MicroarrayVarianceHeatmap, 3) MicroarrayArtifactDetection, and 4) 
MicroarrayGeneCalculations (see Figure 36). These grid services are constructed using 
the Introduce software from caBIG and follows the caBIG compatibility guidelines [184]. 
These guidelines require well-documented APIs, reuse of existing caBIG infrastructure 
and data models where possible, and preparation of vocabulary terms for mapping to the 
Enterprise Vocabulary Services. 
Adopting caNanoLab Technology for Laboratory Information Management 
A number of preparatory actions were taken in order to smooth the way toward 
effective involvement with the caBIG initiative. These included attendance at caBIG 
Annual meetings for three consecutive years, face-to-face meetings with leaders in the 
Integrative Cancer Research (ICR) workspace (including traveling for a meeting in 
Boston in October), presentations of an overview of caCORRECT on a scheduled ICR 
conference call. Most importantly, however, was our demonstration of technical abilities 
by adopting the caNanoLab application and the demonstration of good will by gathering 
useful feedback from the members of Dr. Shuming Nie’s nanotechnology laboratory for 
the caNanoLab development team. caNanoLab is a knowledge management application 
developed by the Nanotechnology Characterization Laboratory and the National Cancer 
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Institute. This tool is an important repository for source characterization data of 
nanoparticles [185]. 
caCORRECT Grid Services System Documentation 
Four grid services have been developed, tested, and deployed to the caGRID 
based on the caCORRECT documentation. These services are currently set up to use 
default datasets for demonstration purposes. The remaining work on this effort is to 
integrate our services with the caARRAY Microarray repository so that grid service users 
may pass any public experiment ID from caARRAY and retrieve caCORRECT analysis 
results for that experiment. This will require the use of a new caGRID architectural 
component, called caGridTransfer, and a new API for caARRAY that was released in 
October 2008. 
Throughout the development of preliminary studies, we have followed good 
software documentation practices. Many of these tools were developed in a team 
environment, with teams made up of undergraduate students, Master’s students, and 
Ph.D. students sharing the tasks of design, development, and testing. This has forced our 
tools to operate in a modular fashion, to allow for the use of many different software 
languages and third-party technologies, and to make use of sensible application 
programming interfaces (APIs).  
The Silver-level Compatibility Review for caBIG required a package containing 
12 pieces of documentation about the project under review. These are: 
1. Brief description of the data system and its design (a Powerpoint 
presentation). 
2. UML Model (Including a class diagram of data classes and a class 
diagram with API interfaces). 
3. Graphical representation of the UML diagrams.  
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4. Semantically annotated XMI file (must be able to load into the Semantic 
Integration Workbench (SIW) tool).  
5. Error log from SIW.  
6. UML Model Submission Form (basic application profile information).  
7. Vocabulary Report.   
8. Standards Report.  
9. Full CDE Use Report (exported from the cancer Data Standards 
Repository (caDSR) Common Data Elements (CDE) Browser). 
10. An API description document (generally automated JavaDocs are used). 
11. Test script(s) demonstrating the use of as many of the API methods as 
possible.  
12. Test log(s) produced from running test scripts. 
The generation of Javadocs was the one notable task for generation of a 
submission package for grid service interoperability certification. It is evident that using 
the Eclipse IDE's GUI for Javadoc generation was the easiest and most efficient method 
for creating Javadocs. All class objects designed in Enterprise Architect have a “notes” 
section of their properties which is translated into Javadoc tags in the Introduce-generated 
code files. The result is of the typical format as shown in Figure 37. The documentation is 
linked with hypertext viewable within a web browser. 
For the submission package, the last important artifacts relating successful design 
and implementation of a grid service are the test scripts and test logs. These files contain 
sample client code required to access your grid service programmatically. Mentors use 
the submitted package to judge CDEs, vocabulary usage, and architecture. Upon 
certification, the project's architecture and annotations will be uploaded into the caDSR 
for use by other projects desiring interoperability. This package was submitted to our 
caBIG mentors on March 15, 2009 and the review should be complete by April 15, 2009. 
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Table 9: Summary of community tools under review or already approved for caBIG 
Silver Compatibility. 
Project Name Bioinformatics Research 
Area 
Number of Common 
Data Elements 
BioConductor Microarray analysis 75 
caBIO Gene-centric data system 369 
caIntegrator/Rembrandt Data source integration 326 
caMOD v2.1 Public cancer models 301 
caTIES Tissue pathology reports 219 
caTissue Core Tissue banking, management 326 
caTRIP  Grid service workflow 96 
caXchange  Clinical trial workflow 19 
Function Express Automated gene annotation 87 
GenePattern Multidisciplinary analysis 187 
PIR  Protein data discovery 197 
ProteomicsLIMS Proteomic lab management 208 
Reactome Curated pathway database 81 
RProteomics Mass spec. analysis 40 
Distributed genomic 
annotation 17 SEED 
Mutation experiment 
management 92 TrAPPS 
Image annotation and 
markup 162 AIM 
geWorkbench Integration and visualization 92 
IVI middleware In Vivo Imaging SDK 209 
Cancer data repository, 
images 107 NCIA 
PSC Clinical trial management 67 
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Figure 36: The four grid services developed for caBIG. These functional services were 
split from the integrated workflow used to drive the caCORRECT web site so that caBIG 
developers could use them within integrated workflows. The TAXY regression algorithm 





Figure 37: Example documentation (JavaDocs) generated for caBIG compatibility 
review. The Application Programming Interface (API) documentation describes each of 
the four analytical services available, as well as what values are expected from the input 






This dissertation presented an information management and visualization platform 
for Translational Biomedical Informatics (TBMI). TBMI is a critical step toward 
personalized medicine because it addresses the inevitable obstacles of information 
overload and more complex interpretations of data relationships. TBMI also includes 
development of common infrastructure like that developed by Cancer Biomedical 
Informatics Grid (caBIG) and standards for data analysis like those developed by the 
FDA MAQC Phase II Project. 
The Concrete Application Deliverables 
The concrete goals of this dissertation were to define and demonstrate key 
technological (or engineering) choices that support the three objectives. These concrete 
engineering choices are:  
1. Development of all software and algorithms using technologies that are 
easily deployed to the web environment and subsequently a community grid environment 
such as caBIG. 
2. Development of metrics for data quality that can be stored and used 
through an integrated system for comparison. 
3. Use and extension of two technologies that allow for a union of data 
visualization and the source data used to generate the visualization (assisting with 
interactive exploration): BioPNG and SVG. 
Four application deliverables demonstrate the concrete choices:  
1. caCORRECT [18] demonstrates a web-based interactive interface using 
SVG, AJAX, and JavaScript. It also includes a data quality metric.  
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2. ArrayWiki [68] is a web-based open editing system for community 
contribution. ArrayWiki exposes the data quality metrics in caCORRECT in a searchable 
repository. It natively supports storage of SVG and PNG visualizations in a flexible 
framework. 
3. BioPNG [68] unites source data with visualization by intelligently 
fragmenting large data values for storage into a 8 or 16-bin 4-channel compressed format. 
A web-based interface allows users to create their own files from source data. 
4. SimpleVisGrid [186] unites source data with visualization by converting 
certain biological source data into SVG files or BioPNG. This application is grid-ready 
and properly modeled for integration with caBIG. 
In addition to application deliverables, two other concrete deliverables were 
accomplished to support the objective of translation. There were: 
1. Participation in the FDA MAQC Phase II Project (as evidenced by 
authorship in the special issue publication). 
2. Submission of a Silver-level Review package for certification of 
caCORRECT Grid Services. 
caCORRECT 
The chip artifact Correction Tool (caCORRECT, http://cacorrect.bme.gatech.edu) 
is a web-based application for identifying data problems on many types of microarrays. 
caCORRECT also includes four caBIG-approved Grid Services for use by the wider 
cancer community in larger experimental workflows. caCORRECT supports Affymetrix 
GeneChip and SNP microarrays. The three major features of caCORRECT are the quality 
score for comparing data sets, the visualization heatmap of chip variance for uncovering 
lab protocol problems, and the calculation of artifact-aware gene expression results for 
more reproducible biomarker results. 
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ArrayWiki 
ArrayWiki (http://arraywiki.bme.gatech.edu) is a community-maintained 
microarray repository. ArrayWiki is different from other microarray repositories 
primarily in the fact that any registered user of the system may edit, add, or re-organize 
experiments within the repository. Other unique features are the inclusion of all quality 
results produced by caCORRECT and a unique data storage format, BioPNG, that 
combines compression and visualization and offers improved security over zip files used 
by other repositories. ArrayWiki contains over 10,000 microarray chips and is steadily 
growing on a daily basis. 
BioPNG and Scalable Vector Graphics 
BioPNG is an open-source data storage algorithm that combines very high 
lossless compression rates with the ability to view data files in nearly all standard image 
viewers or editors in addition to web browsers. For this reason, it is highly portable and 
allows users to easily verify common corruption issues that may be missed when formats 
that do not offer visualization are used. BioPNG is flexible enough to support very large 
integers in addition to very precise decimal values as well as three-dimensional data 
using the Animated PNG (APNG) format. 
SimpleVisGrid is a collection of grid-enabled visualization services that all offer 
the unique feature of wrapping source data into the same file format with the 
visualization data. This allows service consumers (e.g. viewer applications) to manipulate 
the underlying data and thus the resulting visualization. This creates more useful and 
engaging graphics because users can explore the data. It also improves the quality of 
communications using data because users can verify assumptions and modify graphics to 
better suit their own particular context. 
 123
Food and Drug Administration Microarray Quality Control Consortium 
The Microarray Quality Control (MAQC) Consortium of the Food and Drug 
Administration (FDA) Center for Toxicological Research and participating institutions is 
a four phase project. Phase I was published in Nature Biotechnology in 2006. The 
purpose of the Phase I effort was to determine if microarrays were technically reliable as 
a data acquisition technology. The Consortium published a set of standards for 
researchers to follow when performing microarray experiments to support New Drug 
Applications (NDAs). The purpose of Phase II is to determine that data analysis protocols 
for mining microarray data are reliable when applied to different clinical datasets. This 
effort will determine if microarray technology can itself be approved for diagnostic or 
prognostic purposes. The secondary goal is to publish standards for building the 
necessary clinical classification models. This dissertation will discuss an effort to 
exhaustively compare all of the properties of the K Nearest Neighbors (KNN) classifier 
as a contribution toward this goal. After Phase II is complete, the MAQC Consortium 
will apply the same rigorous study to Next Generation Sequencing (NGS) technologies 
such as Roche 454, Illumina Genome Analyzer, Applied Biosystems Supported Oligo 
Ligation Detection (SOLiD) technology and Helicos Biosciences HeliScope Sequencer. 
Cancer Biomedical Informatics Grid (caBIG) Certified Services 
Four grid service interfaces were developed to correspond to the key functional 
offerings of caCORRECT: 1) MicroarrayQualityScore, 2) MicroarrayVarianceHeatmap, 
3) MicroarrayArtifactDetection, and 4) MicroarrayGeneCalculations. A fully-annotated 
UML model accompanied these services and all of the input and output data elements are 
registered in the Cancer Data Standards Repository (caDSR). A submission package was 
prepared for the Silver-level certification review committee. This package included 
JavaDoc documentation, a testing plan and test scripts in addition to the UML model. A 
decision is expected on the certification in early April. 
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Future Impacts of this Work 
Of the key contributions of this work, some may seem to be obvious extensions of 
well-known “good science” principles. For example, the importance of having a very 
deep understanding of the data that you are working with has been stressed since the 
early days of data analysis. However, it is important to note that the preponderance of 
data available today combined with the increasingly complex methods used for high-
throughput data acquisition mean that scientists must become increasingly specialized in 
order to accomplish this deep understanding. This specialization of many scientists 
creates a need for better systems and more standardization to help the specialists work 
together on team projects. The problems of modern science are no longer solvable by an 
independent researcher. Participation in “Team Science” and embracing this new culture 
of scientific research has been one of the most inspiring and gratifying parts of working 
on this dissertation. 
Many well-known Internet gurus such as Tim Berners-Lee are saying that the next 
10 years will be marked by an enormous rise in “linked data” as contrasted to the 
previous emergence of “linked documents.” Tim O’Reilly calls this new phase of Internet 
evolution “Web 2.0.” I am proud to say that ArrayWiki displays all of the characteristics 
of a Web 2.0 Platform as spelled out by the authors of Wikipedia (see 
http://en.wikipedia.org/wiki/Web_2.0). I think that use of image formats to pass raw data 
in open transactions will become another important feature of Web 2.0 that does not yet 
have full recognition. I never cease to be amazed by the inventive minds of my fellow 
software developers and of the rapid pace of innovation spurred on by increased 
connectivity of such able minds. I hope that this work can inspire some of those young 
minds to direct their passion at solving some of the greatest problems yet: human disease 
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GLOSSARY OF TERMS 
Adaptability – a measure of the projected useful lifetime of a computational solution. 
This factor is greatly influenced by behind-the-scenes design decisions, such as the 
development, database, and deployment platforms and also the modularity of the code. 
Each enhancement requested by users will cause the development team to consider a 
complete rewrite of the system. Meanwhile, the development team will experience 
turnover, with new members bringing on new skills. Over time, the likelihood of a 
complete rewrite approaches inevitability. However, useful and adaptable solutions that 
require fairly low maintenance tend to transition over time from one solution to the next. 
 
AJAX – Asynchronous JavaScript and XML, a technique for making web pages more 
interactive by allowing small modules within the page to exchange information with the 
server without rendering the entire page each time. AJAX is not a standalone technology, 
but rather a grouping of existing technologies used in a special way. 
 
Batch effect - The effect of "the day of the assay" on microarray gene expression.  In 
other words, microarray data from a particular day, or batch of reagent, may have a range 
of expression values that differs from other days or reagents.  Without checking for a 
batch effect, a microarray dataset may suggest a set of differentially expressed genes 
reflects clinical categories, when in fact the genes are all artifacts.  It is important to plan 
for batch effects when planning how samples will be analyzed.  Samples from different 
clinical categories should not be analyzed together on separate days.  Rather, it is better 
to run samples from different clinical categories in the same batch. 
 
BioPAX - Biological Pathway data-exchange. An RDF-based biological pathway data 
exchange format. The current release is Level 2, version 1.0. This version integrates 
Reactome (http://reactome.org/). BioPAX began at the Fourth BioPathways Consortium 
Meeting at Intelligent Systems in Molecular Biology (ISMB) August 2002 in Edmonton, 
Canada. 
 
BPEL4WS – Business Process Execution Language for Web Services, a language for 
formal specification of business interactions. BPEL4WS is intended to expand the role of 
automated process integration in corporate and business-to-business space. It is an 
example of workflow creation technology that may be extended to biomedical research 
workflows. 
 
caBIG – Cancer Bioinformatics Grid, the proposed World Wide Web of cancer research, 
steered and developed primarily at the National Cancer Institute (NCI) of the National 
Institutes of Health (NIH) branch of the United States government. 
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caBIO - Cancer Bioinformatics Infrastructure Objects, an Application Programming 
Interface (API) developed first as Java objects but extended to support various 
programming platforms. These objects represent the most fundamental concepts in 
bioinformatics research, such as Gene, Ontology, and Sequence. 
 
caDSR - Cancer Data Standards Repository, a Data Dictionary for bioinformatics 
research. The purpose of caDSR is for data definitions in bioinformatics software to 
become uniform. For example, if a Gene data object is defined in 34 approved caBIG 
applications, that data object should contain uniform fields, properties, and methods 
across these applications to aid in understanding and interoperability. If your application 
uses caBIO objects exclusively, you automatically fulfill this requirement. 
 
CDE - Common Data Element, a term for each data definition in caDSR. 
 
Cross-validation - A method of repeatedly partitioning the data into separate training 
and testing sets.  Because of these reiterations, every sample becomes used in training 
and testing capacities.  To avoid introducing bias, the biostatistician can resort to use of a 
holdout set. 
 
DTD - Document Type Definition, a fundamental XML concept that preceded the XSD. 
DTDs simply indicated the expected structure of an incoming XML document and could 
be used for validation. 
 
EVS - Enterprise Vocabulary Services, a caBIG ontology unification initiative intended 
to provide a one-stop resource for cancer-related word definitions. EVS incorporates 
many other medical ontologies. 
 
External validation - Validation of a microarray predictor using a dataset that was not 
used in the development of the microarray predictor. 
 
GO - Gene Ontology, an early effort in biological ontologies. The goal of GO is to 
capture relationships between discoveries about the functional roles of genes in 
organisms in an hierarchical structure. 
 
HTML - HyperText Markup Language, the basic communication language of the World 
Wide Web. HTML is intended to format data for visual appeal to human users, as 
opposed to XML, which is data formatting for software consumption. 
 
Interoperability – a measure of how well a system developed by one team of people can 
coordinate workflows with all other systems in use by the user community. 
Interoperability is too often applied only to tools when what is really the currency of the 
underlying interoperability of tools is the data. So while data standards are incorporated 
at the tool level, the development of those standards is independent of tools and only 
considers data requirements of the domain. 
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LSID - Life Science Identifier (http://sourceforge.net/projects/lsid/), under the oversight 
of the Interoperable Informatics Infrastructure Consortium (I3C) and IBM, LSID is 
intended to provide a uniform way to name and locate life science data. The vision of the 
LSID is that computational scientists could associate them with applications for 
visualization and analysis, thus improving semantic integration. 
 
MAGE-ML – Microarray Gene Expression Markup Language, an XML schema 
resulting from the call for more meta-data about microarray experiments to improve 
comparison and validate reproducibility. MAGE-ML is now integrated into many well-
established microarray databases. 
 
MathML – Mathematics Markup Language, an XML schema for visual representation of 
mathematical equations. MathML can be parsed by software which interprets and uses 
the equations for analysis and modeling, but does not specify how an equation should be 
used in its specification. 
 
Matthew’s correlation coefficient - A performance measure of microarray 
predictiveness.  The Pearson correlation coefficient provides the same number for binary 
data. 
 
MyGrid – (not an acronym), a bioinformatics workflow integration effort originating in 
the UK. MyGrid uses the Scufl workflow description language and the Taverna 
workbench user interface for building the workflows. They current hot project is the 
myExperiment portal for sharing workflows among the community.  
 
Normalization - The process of aligning gene expression measures from different 
microarrays, so that a comparison can occur.  The goal of normalization is to avoid 
spurious differences between sample categories.  Normalization traditionally consists of 
two components: 1) mean centering (in which the global mean expression value of all the 
probes in the microarrays are calculated and the differences in these means subtracted) 2) 
scaling (in which gene expression values after mean centering are divided by the 
estimated global variance).  Quantile normalization, in which normalization proceeds 
through ranked gene expression quantiles of the microarray data, is an example.  
Normalization, itself, can introduce spurious findings.  Therefore, some microarray 
analysis plans may incorporate an examination of the data without normalization. 
 
OWL - Web Ontology Language, an XML schema for defining ontologies. A great result 
of OWL is to aid the integration of ontologies from different sources. OWL incorporates 
concepts defined by RDF. 
 
Pre-analysis - A "first look" at the data to identify unusual situations and as a quality 
control check.  Pre-analysis tasks may include outlier identification, batch effect 
determination, and determination if a statistically significant difference in gene 
expression exists between clinical categories (prior to modeling). 
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RDF - Resource Description Framework, an XML schema for defining tertiary 
relationships (i.e. subject, predicate, object). Each of the three elements of the tertiary 
relationship is considered a resource and thus a hub of other tertiary relationships. RDF is 
now in widespread use as a fundamental semantic structure for more specific efforts 
toward software that “understands” data. 
 
Reliability - The similarity between performances of a predictive model as estimated 
during cross-validation and performance of that predictive model during external 
validation. Or, the similarity between performance of a DAP as estimated on one dataset, 
and performance of that DAP on a new dataset (including swapping of training and test 
data). 
 
Reproducibility - The similarity between performance of a DAP as conducted by the 
original DAP authors and performance of a reimplementation of that DAP by a different 
team. 
 
Semantic Web – A proposed extension to the existing World Wide Web where web-
based documents and content contain machine-readable instructions for how computers 
should interpret the meaning of the content. The goal of the Semantic Web is to increase 
the usability of the Internet by allowing a user to execute automated, highly complex 
goal-based searches, thus reducing the amount of time spent “surfing”. 
 
SBML – Systems Biology Markup Language, an XML schema for defining biochemical 
reaction models in systems biology. SBML is in widespread use and is supported by 
more than 70 systems biology modeling software packages. 
 
SBGN – Systems Biology Graphics Notation, a collection of symbols for the presentation 
of biochemical reaction networks. The symbolic language is not intended to convey a 
mathematically precise description of the behavior of the network, but rather to give a 
qualitative description.  
 
SVG - Scalable Vector Graphics, an XML schema for two dimensional graphics 
representation. SVG defines basic elements such as shapes, images, gradients and 
symbols (complex shapes). SVG is natively supported by most modern web browsers, 
allowing developers to create richly-varied user interfaces, rather than the standard 
HTML forms offered up to this point by all web sites. SVG is most easily compared to 
Java applets or Macromedia Flash from the user perspective, but is actually vastly 
different in the sense that it is open and scalable. 
 
UDDI - Universal Description, Discovery, and Integration directory, a directory of web 
services. UDDI is a cross-industry effort driven by major platform and service providers 
within the OASIS standards consortium. UDDI can be used in a single-registry or 
distributed-registry approach, but does not specify how interactions between registries 
might take place. 
 
 133
UMLS - Unified Medical Language System, an ontology of medical terms with cross-
references. UMLS is one of the source ontologies of caBIG’s EVS. 
 
URN - Universal Resource Names, the Web addressing scheme that allows a text string 
to be used to identify and locate resources on the network. URN is synonymous with the 
more common URLs published by any groups with a web presence. 
 
WSDL - Web Services Description Language, an XML schema for identifying the 
purpose and interaction schemes of web services. WSDL does not describe web service 
location strategies but is a successful standard in that all location strategies have adopted 
WSDL for description. 
 
XML - Extensible Markup Language, the fundamental technology behind most text-
based data identification and location schemes. Some might say that HTML is just 
another implementation of an XML schema, although it came into widespread use much 
earlier. 
 
XSD - XML Schema Definition, a text document that specifies the structure of other 
XML documents. XSDs do not contain any data, only meta-data such as names and types 
and hierarchical structure. XSDs are the successor to DTDs and provide more precise 
definition for the purposes of validation. 
 
Usability – a measure of usefulness of a computational solution. This is often measured 
directly by user satisfaction surveys, but may also be aggregated with quantitative 
measures of complexity (number of lines of code, screens, buttons, menus) and the raw 
growth of the user base (e.g. the users may be largely dissatisfied, but the demand is so 
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